{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:14:05Z","timestamp":1791296045140,"version":"4.1.0"},"publisher-location":"Singapore","reference-count":239,"publisher":"Springer Nature Singapore","isbn-type":[{"value":"9789811973758","type":"print"},{"value":"9789811973765","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-981-19-7376-5_7","type":"book-chapter","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T17:03:57Z","timestamp":1679504637000},"page":"135-160","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["C-Reactive Protein (CRP): A Potent Inflammation Biomarker in Psychiatric Disorders"],"prefix":"10.1007","author":[{"given":"Laura","family":"Orsolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Pompili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,23]]},"reference":[{"issue":"2","key":"7_CR1","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.clim.2005.08.004","volume":"117","author":"L Marnell","year":"2005","unstructured":"Marnell L, Mold C, Du Clos TW. C-reactive protein: ligands, receptors and role in inflammation. Clin Immunol. 2005;117(2):104\u201311. https:\/\/doi.org\/10.1016\/j.clim.2005.08.004.","journal-title":"Clin Immunol"},{"key":"7_CR2","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3389\/fimmu.2018.00754","volume":"9","author":"NR Sproston","year":"2018","unstructured":"Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol. 2018;9:754. https:\/\/doi.org\/10.3389\/fimmu.2018.00754.","journal-title":"Front Immunol"},{"key":"7_CR3","volume-title":"C reactive protein","author":"SM Nehring","year":"2021","unstructured":"Nehring SM, Goyal A, Bansal P, Patel BC. C reactive protein. Treasure Island, FL: StatPearls; 2021. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK441843\/."},{"issue":"4","key":"7_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1084\/jem.52.4.561","volume":"52","author":"WS Tillett","year":"1930","unstructured":"Tillett WS, Francis T. Serological reactions in pneumonia with a non-protein somatic fraction of pneumococcus. J Exp Med. 1930;52(4):561\u201371. https:\/\/doi.org\/10.1084\/jem.52.4.561.","journal-title":"J Exp Med"},{"issue":"11","key":"7_CR5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1515\/hsz-2015-0149","volume":"396","author":"Y Wu","year":"2015","unstructured":"Wu Y, Potempa LA, El Kebir D, Filep JG. C-reactive protein and inflammation: conformational changes affect function. Biol Chem. 2015;396(11):1181\u201397. https:\/\/doi.org\/10.1515\/hsz-2015-0149.","journal-title":"Biol Chem"},{"issue":"1","key":"7_CR6","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/CIRCULATIONAHA.113.007124","volume":"130","author":"JR Thiele","year":"2014","unstructured":"Thiele JR, Habersberger J, Braig D, Schmidt Y, Goerendt K, Maurer V, et al. Dissociation of pentameric to monomeric C-reactive protein localizes and aggravates inflammation: in vivo proof of a powerful proinflammatory mechanism and a new anti-inflammatory strategy. Circulation. 2014;130(1):35\u201350. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.113.007124.","journal-title":"Circulation"},{"issue":"1\u20132","key":"7_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.schres.2015.08.019","volume":"168","author":"J Joseph","year":"2015","unstructured":"Joseph J, Depp C, Martin AS, Daly RE, Glorioso DK, Palmer BW, et al. Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groups. Schizophr Res ottobre. 2015;168(1\u20132):456\u201360. https:\/\/doi.org\/10.1016\/j.schres.2015.08.019.","journal-title":"Schizophr Res ottobre"},{"issue":"3","key":"7_CR8","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1161\/01.cir.0000053730.47739.3c","volume":"107","author":"PM Ridker","year":"2003","unstructured":"Ridker PM. Clinical application of C-reactive protein for cardiovascular disease detection and prevention. Circulation. 2003;107(3):363\u20139. https:\/\/doi.org\/10.1161\/01.cir.0000053730.47739.3c.","journal-title":"Circulation"},{"issue":"5","key":"7_CR9","doi-asserted-by":"publisher","first-page":"583","DOI":"10.2174\/1570159X16666180119144538","volume":"16","author":"L Orsolini","year":"2018","unstructured":"Orsolini L, Sarchione F, Vellante F, Fornaro M, Matarazzo I, Martinotti G, et al. Protein-C reactive as biomarker predictor of schizophrenia phases of illness?: a systematic review. Curr Neuropharmacol. 2018;16(5):583\u2013606. https:\/\/doi.org\/10.2174\/1570159X16666180119144538.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"7_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.cir.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499\u2013511. https:\/\/doi.org\/10.1161\/01.cir.0000052939.59093.45.","journal-title":"Circulation"},{"key":"7_CR11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.neubiorev.2014.05.007","volume":"45","author":"S Moylan","year":"2014","unstructured":"Moylan S, Berk M, Dean OM, Samuni Y, Williams LJ, O\u2019Neil A, et al. Oxidative & nitrosative stress in depression: why so much stress? Neurosci Biobehav Rev. 2014;45:46\u201362. https:\/\/doi.org\/10.1016\/j.neubiorev.2014.05.007.","journal-title":"Neurosci Biobehav Rev"},{"issue":"1","key":"7_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/npp.2016.146","volume":"42","author":"V Michopoulos","year":"2017","unstructured":"Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology. 2017;42(1):254\u201370. https:\/\/doi.org\/10.1038\/npp.2016.146.","journal-title":"Neuropsychopharmacology"},{"issue":"11","key":"7_CR13","doi-asserted-by":"publisher","first-page":"E144","DOI":"10.3390\/brainsci7110144","volume":"7","author":"JD Rosenblat","year":"2017","unstructured":"Rosenblat JD, McIntyre RS. Bipolar disorder and immune dysfunction: epidemiological findings, proposed pathophysiology and clinical implications. Brain Sci. 2017;7(11):E144.","journal-title":"Brain Sci"},{"issue":"Suppl 7","key":"7_CR14","first-page":"447","volume":"30","author":"T Dubois","year":"2018","unstructured":"Dubois T, Reynaert C, Jacques D, Lepiece B, Patigny P, Zdanowicz N. Immunity and psychiatric disorders: variabilities of immunity biomarkers are they specific? Psychiatr Danub. 2018;30(Suppl 7):447\u201351.","journal-title":"Psychiatr Danub"},{"key":"7_CR15","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.bbi.2018.06.016","volume":"73","author":"SR Horn","year":"2018","unstructured":"Horn SR, Long MM, Nelson BW, Allen NB, Fisher PA, Byrne ML. Replication and reproducibility issues in the relationship between C-reactive protein and depression: a systematic review and focused meta-analysis. Brain Behav Immun. 2018;73:85\u2013114. https:\/\/doi.org\/10.1016\/j.bbi.2018.06.016.","journal-title":"Brain Behav Immun"},{"issue":"11","key":"7_CR16","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1002\/da.22790","volume":"35","author":"ME Renna","year":"2018","unstructured":"Renna ME, O\u2019Toole MS, Spaeth PE, Lekander M, Mennin DS. The association between anxiety, traumatic stress, and obsessive-compulsive disorders and chronic inflammation: a systematic review and meta-analysis. Depress Anxiety. 2018;35(11):1081\u201394. https:\/\/doi.org\/10.1002\/da.22790.","journal-title":"Depress Anxiety"},{"issue":"6","key":"7_CR17","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1038\/s41380-018-0096-3","volume":"25","author":"JC Felger","year":"2020","unstructured":"Felger JC, Haroon E, Patel TA, Goldsmith DR, Wommack EC, Woolwine BJ, et al. What does plasma CRP tell us about peripheral and central inflammation in depression? Mol Psychiatry. 2020;25(6):1301\u201311. https:\/\/doi.org\/10.1038\/s41380-018-0096-3.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1002\/jnr.24331","volume":"98","author":"S Sulhan","year":"2020","unstructured":"Sulhan S, Lyon KA, Shapiro LA, Huang JH. Neuroinflammation and blood-brain barrier disruption following traumatic brain injury: pathophysiology and potential therapeutic targets. J Neurosci Res. 2020;98(1):19\u201328. https:\/\/doi.org\/10.1002\/jnr.24331.","journal-title":"J Neurosci Res"},{"issue":"4","key":"7_CR19","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1111\/acps.13175","volume":"142","author":"J Turna","year":"2020","unstructured":"Turna J, Grosman Kaplan K, Anglin R, Patterson B, Soreni N, Bercik P, et al. The gut microbiome and inflammation in obsessive-compulsive disorder patients compared to age- and sex-matched controls: a pilot study. Acta Psychiatr Scand. 2020;142(4):337\u201347. https:\/\/doi.org\/10.1111\/acps.13175.","journal-title":"Acta Psychiatr Scand"},{"key":"7_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2021.110604","volume":"150","author":"D Caldirola","year":"2021","unstructured":"Caldirola D, Dacc\u00f2 S, Cuniberti F, Grassi M, Lorusso S, Diaferia G, et al. Elevated C-reactive protein levels across diagnoses: the first comparison among inpatients with major depressive disorder, bipolar disorder, or obsessive\u2013compulsive disorder. J Psychosom Res. 2021;150:110604. https:\/\/doi.org\/10.1016\/j.jpsychores.2021.110604.","journal-title":"J Psychosom Res"},{"issue":"1","key":"7_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1038\/s41380-019-0479-0","volume":"25","author":"JJ Woo","year":"2020","unstructured":"Woo JJ, Pouget JG, Zai CC, Kennedy JL. The complement system in schizophrenia: where are we now and what\u2019s next? Mol Psychiatry. 2020;25(1):114\u201330. https:\/\/doi.org\/10.1038\/s41380-019-0479-0.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"7_CR22","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1523\/JNEUROSCI.3567-08.2009","volume":"29","author":"C D\u2019Mello","year":"2009","unstructured":"D\u2019Mello C, Le T, Swain MG. Cerebral microglia recruit monocytes into the brain in response to tumor necrosis factor signaling during peripheral organ inflammation. J Neurosci. 2009;29(7):2089\u2013102. https:\/\/doi.org\/10.1523\/JNEUROSCI.3567-08.2009.","journal-title":"J Neurosci"},{"issue":"6","key":"7_CR23","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1038\/mp.2017.64","volume":"23","author":"DB McKim","year":"2018","unstructured":"McKim DB, Weber MD, Niraula A, Sawicki CM, Liu X, Jarrett BL, et al. Microglial recruitment of IL-1\u03b2-producing monocytes to brain endothelium causes stress-induced anxiety. Mol Psychiatry. 2018;23(6):1421\u201331. https:\/\/doi.org\/10.1038\/mp.2017.64.","journal-title":"Mol Psychiatry"},{"key":"7_CR24","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.3389\/fimmu.2019.02066","volume":"10","author":"R Wesselingh","year":"2019","unstructured":"Wesselingh R, Butzkueven H, Buzzard K, Tarlinton D, O\u2019Brien TJ, Monif M. Innate immunity in the central nervous system: a missing piece of the autoimmune encephalitis puzzle? Front Immunol. 2019;10:2066. https:\/\/doi.org\/10.3389\/fimmu.2019.02066.","journal-title":"Front Immunol"},{"issue":"11","key":"7_CR25","doi-asserted-by":"publisher","first-page":"2872","DOI":"10.2337\/db09-1606","volume":"59","author":"CA Aveleira","year":"2010","unstructured":"Aveleira CA, Lin C-M, Abcouwer SF, Ambrosio AF, Antonetti DA. TNF- signals through PKC\/NF- B to alter the tight junction complex and increase retinal endothelial cell permeability. Diabetes. 2010;59(11):2872\u201382. https:\/\/doi.org\/10.2337\/db09-1606.","journal-title":"Diabetes"},{"issue":"12","key":"7_CR26","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1016\/j.bbi.2016.09.008","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20(12):1752\u201360. https:\/\/doi.org\/10.1016\/j.bbi.2016.09.008.","journal-title":"Nat Neurosci"},{"key":"7_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101333","volume":"68","author":"M-T Jeon","year":"2021","unstructured":"Jeon M-T, Kim K-S, Kim ES, Lee S, Kim J, Hoe H-S, et al. Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease. Ageing Res Rev. 2021;68:101333. https:\/\/doi.org\/10.1016\/j.arr.2021.101333.","journal-title":"Ageing Res Rev"},{"issue":"6","key":"7_CR28","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1097\/WCO.0000000000000248","volume":"28","author":"R Prakash","year":"2015","unstructured":"Prakash R, Carmichael ST. Blood\u2212brain barrier breakdown and neovascularization processes after stroke and traumatic brain injury. Curr Opin Neurol. 2015;28(6):556\u201364. https:\/\/doi.org\/10.1097\/WCO.0000000000000248.","journal-title":"Curr Opin Neurol"},{"issue":"4","key":"7_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1161\/STROKEAHA.108.535930","volume":"40","author":"CRW Kuhlmann","year":"2009","unstructured":"Kuhlmann CRW, Librizzi L, Closhen D, Pflanzner T, Lessmann V, Pietrzik CU, et al. Mechanisms of C-reactive protein-induced blood\u2013brain barrier disruption. Stroke. 2009;40(4):1458\u201366. https:\/\/doi.org\/10.1161\/STROKEAHA.108.535930.","journal-title":"Stroke"},{"issue":"1","key":"7_CR30","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/s41598-018-21243-x","volume":"8","author":"GY Lim","year":"2018","unstructured":"Lim GY, Tam WW, Lu Y, Ho CS, Zhang MW, Ho RC. Prevalence of depression in the community from 30 countries between 1994 and 2014. Sci Rep. 2018;8(1):2861. https:\/\/doi.org\/10.1038\/s41598-018-21243-x.","journal-title":"Sci Rep"},{"issue":"1","key":"7_CR31","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s00441-018-2978-8","volume":"377","author":"L Perez-Caballero","year":"2019","unstructured":"Perez-Caballero L, Torres-Sanchez S, Romero-L\u00f3pez-Alberca C, Gonz\u00e1lez-Saiz F, Mico JA, Berrocoso E. Monoaminergic system and depression. Cell Tissue Res. 2019;377(1):107\u201313. https:\/\/doi.org\/10.1007\/s00441-018-2978-8.","journal-title":"Cell Tissue Res"},{"issue":"1","key":"7_CR32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11011-008-9118-1","volume":"24","author":"M Maes","year":"2009","unstructured":"Maes M, Yirmyia R, Noraberg J, Brene S, Hibbeln J, Perini G, et al. The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression. Metab Brain Dis. 2009;24(1):27\u201353. https:\/\/doi.org\/10.1007\/s11011-008-9118-1.","journal-title":"Metab Brain Dis"},{"issue":"4","key":"7_CR33","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/mp.2016.120","volume":"22","author":"J Keller","year":"2017","unstructured":"Keller J, Gomez R, Williams G, Lembke A, Lazzeroni L, Murphy GM, et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol Psychiatry. 2017;22(4):527\u201336. https:\/\/doi.org\/10.1038\/mp.2016.120.","journal-title":"Mol Psychiatry"},{"key":"7_CR34","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pnpbp.2017.06.036","volume":"80","author":"P Czarny","year":"2018","unstructured":"Czarny P, Wigner P, Galecki P, Sliwinski T. The interplay between inflammation, oxidative stress, DNA damage, DNA repair and mitochondrial dysfunction in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;80:309\u201321. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.06.036.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"3","key":"7_CR35","doi-asserted-by":"publisher","first-page":"437","DOI":"10.12740\/PP\/76863","volume":"52","author":"P Ga\u0142ecki","year":"2018","unstructured":"Ga\u0142ecki P, Talarowska M. Inflammatory theory of depression. Psychiatr Pol. 2018;52(3):437\u201347.","journal-title":"Psychiatr Pol"},{"issue":"4","key":"7_CR36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/pcn.12621","volume":"72","author":"S Uchida","year":"2018","unstructured":"Uchida S, Yamagata H, Seki T, Watanabe Y. Epigenetic mechanisms of major depression: targeting neuronal plasticity. Psychiatry Clin Neurosci. 2018;72(4):212\u201327. https:\/\/doi.org\/10.1111\/pcn.12621.","journal-title":"Psychiatry Clin Neurosci"},{"key":"7_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.pnpbp.2017.05.023","volume":"80","author":"P Ga\u0142ecki","year":"2018","unstructured":"Ga\u0142ecki P, Talarowska M. Neurodevelopmental theory of depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;80:267\u201372. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.05.023.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"7_CR38","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/j.bbi.2020.02.010","volume":"87","author":"EF Osimo","year":"2020","unstructured":"Osimo EF, Pillinger T, Rodriguez IM, Khandaker GM, Pariante CM, Howes OD. Inflammatory markers in depression: a meta-analysis of mean differences and variability in 5,166 patients and 5,083 controls. Brain Behav Immun. 2020;87:901\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2020.02.010.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"7_CR39","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","volume":"67","author":"Y Dowlati","year":"2010","unstructured":"Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446\u201357. https:\/\/doi.org\/10.1016\/j.biopsych.2009.09.033.","journal-title":"Biol Psychiatry"},{"key":"7_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.bbi.2015.06.001","volume":"49","author":"R Haapakoski","year":"2015","unstructured":"Haapakoski R, Mathieu J, Ebmeier KP, Alenius H, Kivim\u00e4ki M. Cumulative meta-analysis of interleukins 6 and 1\u03b2, tumour necrosis factor \u03b1 and C-reactive protein in patients with major depressive disorder. Brain Behav Immun. 2015;49:206\u201315. https:\/\/doi.org\/10.1016\/j.bbi.2015.06.001.","journal-title":"Brain Behav Immun"},{"issue":"12","key":"7_CR41","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696\u2013709. https:\/\/doi.org\/10.1038\/mp.2016.3.","journal-title":"Mol Psychiatry"},{"issue":"12","key":"7_CR42","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.3390\/jcm9123793","volume":"9","author":"A Nobis","year":"2020","unstructured":"Nobis A, Zalewski D, Waszkiewicz N. Peripheral markers of depression. J Clin Med. 2020;9(12):3793. https:\/\/doi.org\/10.3390\/jcm9123793.","journal-title":"J Clin Med"},{"issue":"3","key":"7_CR43","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ncl.2006.03.003","volume":"24","author":"R Dantzer","year":"2006","unstructured":"Dantzer R. Cytokine, sickness behavior, and depression. Neurol Clin. 2006;24(3):441\u201360. https:\/\/doi.org\/10.1016\/j.ncl.2006.03.003.","journal-title":"Neurol Clin"},{"issue":"2","key":"7_CR44","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1001\/2013.jamapsychiatry.102","volume":"70","author":"MK Wium-Andersen","year":"2013","unstructured":"Wium-Andersen MK, \u00d8rsted DD, Nielsen SF, Nordestgaard BG. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiat. 2013;70(2):176. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.102.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"7_CR45","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1017\/S0033291710000887","volume":"41","author":"O Bjerkeset","year":"2011","unstructured":"Bjerkeset O, Romild U, Smith GD, Hveem K. The associations of high levels of C-reactive protein with depression and myocardial infarction in 9258 women and men from the HUNT population study. Psychol Med. 2011;41(2):345\u201352. https:\/\/doi.org\/10.1017\/S0033291710000887.","journal-title":"Psychol Med"},{"issue":"5","key":"7_CR46","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1192\/bjp.bp.109.076430","volume":"197","author":"JA Pasco","year":"2010","unstructured":"Pasco JA, Nicholson GC, Williams LJ, Jacka FN, Henry MJ, Kotowicz MA, et al. Association of high-sensitivity C-reactive protein with de novo major depression. Br J Psychiatry. 2010;197(5):372\u20137. https:\/\/doi.org\/10.1192\/bjp.bp.109.076430.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"7_CR47","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s10865-013-9510-0","volume":"37","author":"RJ Hickman","year":"2014","unstructured":"Hickman RJ, Khambaty T, Stewart JC. C-reactive protein is elevated in atypical but not nonatypical depression: data from the National Health and nutrition examination survey (NHANES) 1999\u20132004. J Behav Med. 2014;37(4):621\u20139. https:\/\/doi.org\/10.1007\/s10865-013-9510-0.","journal-title":"J Behav Med"},{"issue":"9","key":"7_CR48","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.psyneuen.2013.01.002","volume":"38","author":"HE Duivis","year":"2013","unstructured":"Duivis HE, Vogelzangs N, Kupper N, de Jonge P, Penninx BWJH. Differential association of somatic and cognitive symptoms of depression and anxiety with inflammation: findings from the Netherlands study of depression and anxiety (NESDA). Psychoneuroendocrinology. 2013;38(9):1573\u201385. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.01.002.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"7_CR49","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1007\/s00213-015-3919-9","volume":"233","author":"A Zalli","year":"2016","unstructured":"Zalli A, Jovanova O, Hoogendijk WJG, Tiemeier H, Carvalho LA. Low-grade inflammation predicts persistence of depressive symptoms. Psychopharmacology. 2016;233(9):1669\u201378. https:\/\/doi.org\/10.1007\/s00213-015-3919-9.","journal-title":"Psychopharmacology"},{"issue":"3","key":"7_CR50","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1017\/S0033291708003723","volume":"39","author":"D Gimeno","year":"2009","unstructured":"Gimeno D, Kivim\u00e4ki M, Brunner EJ, Elovainio M, De Vogli R, Steptoe A, et al. Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study. Psychol Med. 2009;39(3):413\u201323. https:\/\/doi.org\/10.1017\/S0033291708003723.","journal-title":"Psychol Med"},{"key":"7_CR51","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.bbi.2017.02.020","volume":"62","author":"O K\u00f6hler-Forsberg","year":"2017","unstructured":"K\u00f6hler-Forsberg O, Buttensch\u00f8n HN, Tansey KE, Maier W, Hauser J, Dernovsek MZ, et al. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Brain Behav Immun. 2017;62:344\u201350. https:\/\/doi.org\/10.1016\/j.bbi.2017.02.020.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"7_CR52","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1192\/bjp.2018.66","volume":"214","author":"SR Chamberlain","year":"2019","unstructured":"Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214(1):11\u20139. https:\/\/doi.org\/10.1192\/bjp.2018.66.","journal-title":"Br J Psychiatry"},{"key":"7_CR53","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.psyneuen.2017.02.019","volume":"79","author":"RJT Mocking","year":"2017","unstructured":"Mocking RJT, Nap TS, Westerink AM, Assies J, Vaz FM, Koeter MWJ, et al. Biological profiling of prospective antidepressant response in major depressive disorder: associations with (neuro)inflammation, fatty acid metabolism, and amygdala-reactivity. Psychoneuroendocrinology. 2017;79:84\u201392. https:\/\/doi.org\/10.1016\/j.psyneuen.2017.02.019.","journal-title":"Psychoneuroendocrinology"},{"issue":"12","key":"7_CR54","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1176\/appi.ajp.2014.14010094","volume":"171","author":"R Uher","year":"2014","unstructured":"Uher R, Tansey KE, Dew T, Maier W, Mors O, Hauser J, et al. An inflammatory biomarker as a differential predictor of outcome of depression treatment with Escitalopram and Nortriptyline. Am J Psychiatry. 2014;171(12):1278\u201386. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14010094.","journal-title":"Am J Psychiatry"},{"issue":"10","key":"7_CR55","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM, Pearson RM, Zammit S, Lewis G, Jones PB. Association of Serum Interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiat. 2014;71(10):1121. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1332.","journal-title":"JAMA Psychiat"},{"issue":"12","key":"7_CR56","doi-asserted-by":"publisher","first-page":"1958","DOI":"10.1017\/S0033291719001454","volume":"49","author":"EF Osimo","year":"2019","unstructured":"Osimo EF, Baxter LJ, Lewis G, Jones PB, Khandaker GM. Prevalence of low-grade inflammation in depression: a systematic review and meta-analysis of CRP levels. Psychol Med. 2019;49(12):1958\u201370. https:\/\/doi.org\/10.1017\/S0033291719001454.","journal-title":"Psychol Med"},{"issue":"3\u20134","key":"7_CR57","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.jpsychires.2006.05.013","volume":"41","author":"SM O\u2019Brien","year":"2007","unstructured":"O\u2019Brien SM, Scully P, Fitzgerald P, Scott LV, Dinan TG. Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy. J Psychiatr Res. 2007;41(3\u20134):326\u201331. https:\/\/doi.org\/10.1016\/j.jpsychires.2006.05.013.","journal-title":"J Psychiatr Res"},{"issue":"1","key":"7_CR58","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.bbi.2011.07.239","volume":"26","author":"HH Chang","year":"2012","unstructured":"Chang HH, Lee IH, Gean PW, Lee S-Y, Chi MH, Yang YK, et al. Treatment response and cognitive impairment in major depression: association with C-reactive protein. Brain Behav Immun. 2012;26(1):90\u20135. https:\/\/doi.org\/10.1016\/j.bbi.2011.07.239.","journal-title":"Brain Behav Immun"},{"issue":"4","key":"7_CR59","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00213-003-1566-z","volume":"170","author":"C Tuglu","year":"2003","unstructured":"Tuglu C, Kara SH, Caliyurt O, Vardar E, Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology. 2003;170(4):429\u201333. https:\/\/doi.org\/10.1007\/s00213-003-1566-z.","journal-title":"Psychopharmacology"},{"issue":"5","key":"7_CR60","doi-asserted-by":"publisher","first-page":"4195","DOI":"10.1007\/s12035-017-0632-1","volume":"55","author":"CA K\u00f6hler","year":"2017","unstructured":"K\u00f6hler CA, Freitas TH, Stubbs B, Maes M, Solmi M, Veronese N, et al. Peripheral alterations in cytokine and chemokine levels after antidepressant drug treatment for major depressive disorder: systematic review and meta-analysis. Mol Neurobiol. 2017;55(5):4195\u2013206. https:\/\/doi.org\/10.1007\/s12035-017-0632-1.","journal-title":"Mol Neurobiol"},{"issue":"8","key":"7_CR61","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.3390\/jcm10081706","volume":"10","author":"A Mosio\u0142ek","year":"2021","unstructured":"Mosio\u0142ek A, Pi\u0119ta A, Jakima S, Zborowska N, Mosio\u0142ek J, Szulc A. Effects of antidepressant treatment on peripheral biomarkers in patients with major depressive disorder (MDD). J Clin Med. 2021;10(8):1706. https:\/\/doi.org\/10.3390\/jcm10081706.","journal-title":"J Clin Med"},{"issue":"1","key":"7_CR62","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL, Rutherford RE, Woolwine BJ, Shuo C, Schettler P, Drake DF, et al. A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat. 2013;70(1):31. https:\/\/doi.org\/10.1001\/2013.jamapsychiatry.4.","journal-title":"JAMA Psychiat"},{"issue":"12","key":"7_CR63","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1001\/jamapsychiatry.2014.1611","volume":"71","author":"O K\u00f6hler","year":"2014","unstructured":"K\u00f6hler O, Benros ME, Nordentoft M, Farkouh ME, Iyengar RL, Mors O, et al. Effect of anti-inflammatory treatment on depression, depressive symptoms, and adverse effects: a systematic review and meta-analysis of randomized clinical trials. JAMA Psychiat. 2014;71(12):1381. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.1611.","journal-title":"JAMA Psychiat"},{"issue":"5","key":"7_CR64","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1001\/jamapsychiatry.2014.3128","volume":"72","author":"HA Eyre","year":"2015","unstructured":"Eyre HA, Baune BT. Anti-inflammatory intervention in depression. JAMA Psychiatry. 2015;72(5):511. https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.3128.","journal-title":"JAMA Psychiatry"},{"key":"7_CR65","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.pnpbp.2014.10.003","volume":"57","author":"HA Eyre","year":"2015","unstructured":"Eyre HA, Air T, Proctor S, Rositano S, Baune BT. A critical review of the efficacy of non-steroidal anti-inflammatory drugs in depression. Prog Neuro-Psychopharmacol Biol Psychiatry. 2015;57:11\u20136. https:\/\/doi.org\/10.1016\/j.pnpbp.2014.10.003.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"7_CR66","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N, Lewis G, Dantzer R, Jones PB, Khandaker GM. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry. 2018;23(2):335\u201343. https:\/\/doi.org\/10.1038\/mp.2016.167.","journal-title":"Mol Psychiatry"},{"key":"7_CR67","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.psyneuen.2018.09.004","volume":"98","author":"M Bekhbat","year":"2018","unstructured":"Bekhbat M, Chu K, Le N-A, Woolwine BJ, Haroon E, Miller AH, et al. Glucose and lipid-related biomarkers and the antidepressant response to infliximab in patients with treatment-resistant depression. Psychoneuroendocrinology. 2018;98:222\u20139. https:\/\/doi.org\/10.1016\/j.psyneuen.2018.09.004.","journal-title":"Psychoneuroendocrinology"},{"key":"7_CR68","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbb.2019.172838","volume":"188","author":"DV Bavaresco","year":"2020","unstructured":"Bavaresco DV, Uggioni MLR, Ferraz SD, Marques RMM, Simon CS, Dagostin VS, et al. Efficacy of infliximab in treatment-resistant depression: a systematic review and meta-analysis. Pharmacol Biochem Behav. 2020;188:172838. https:\/\/doi.org\/10.1016\/j.pbb.2019.172838.","journal-title":"Pharmacol Biochem Behav"},{"key":"7_CR69","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.psychres.2016.02.022","volume":"243","author":"H Liu","year":"2016","unstructured":"Liu H, Zhang Y, Gao Y, Zhang Z. Elevated levels of Hs-CRP and IL-6 after delivery are associated with depression during the 6 months post partum. Psychiatry Res. 2016;243:43\u20138. https:\/\/doi.org\/10.1016\/j.psychres.2016.02.022.","journal-title":"Psychiatry Res"},{"issue":"6","key":"7_CR70","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s00737-018-0834-1","volume":"21","author":"R Buglione-Corbett","year":"2018","unstructured":"Buglione-Corbett R, Deligiannidis K, Leung K, Zhang N, Lee M, Rosal M, et al. Expression of inflammatory markers in women with perinatal depressive symptoms. Arch Womens Ment Health. 2018;21(6):671\u20139. https:\/\/doi.org\/10.1007\/s00737-018-0834-1.","journal-title":"Arch Womens Ment Health"},{"issue":"7","key":"7_CR71","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1177\/0706743719828970","volume":"64","author":"M Lambert","year":"2019","unstructured":"Lambert M, Gressier F. Biomarqueurs de L\u2019inflammation et d\u00e9pression du post-partum: une revue syst\u00e9matique de la litt\u00e9rature. Can J Psychiatr. 2019;64(7):471\u201381. https:\/\/doi.org\/10.1177\/0706743719828970.","journal-title":"Can J Psychiatr"},{"issue":"1","key":"7_CR72","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s00737-018-0841-2","volume":"22","author":"ES Miller","year":"2019","unstructured":"Miller ES, Hoxha D, Pinheiro E, Grobman WA, Wisner KL. The association of serum C-reactive protein with the occurrence and course of postpartum depression. Arch Womens Ment Health. 2019;22(1):129\u201332.","journal-title":"Arch Womens Ment Health"},{"issue":"2","key":"7_CR73","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1007\/s12035-016-9741-5","volume":"54","author":"C Roomruangwong","year":"2017","unstructured":"Roomruangwong C, Kanchanatawan B, Sirivichayakul S, Mahieu B, Nowak G, Maes M. Lower serum zinc and higher CRP strongly predict prenatal depression and Physio-somatic symptoms, which all together predict postnatal depressive symptoms. Mol Neurobiol. 2017;54(2):1500\u201312. https:\/\/doi.org\/10.1007\/s12035-016-9741-5.","journal-title":"Mol Neurobiol"},{"key":"7_CR74","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2019.104558","volume":"113","author":"M Aas","year":"2020","unstructured":"Aas M, Vecchio C, Pauls A, Mehta M, Williams S, Hazelgrove K, et al. Biological stress response in women at risk of postpartum psychosis: the role of life events and inflammation. Psychoneuroendocrinology. 2020;113:104558. https:\/\/doi.org\/10.1016\/j.psyneuen.2019.104558.","journal-title":"Psychoneuroendocrinology"},{"issue":"8","key":"7_CR75","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/dev.21982","volume":"62","author":"JE Morgan","year":"2020","unstructured":"Morgan JE, Lee SS, Mahrer NE, Guardino CM, Davis EP, Shalowitz MU, et al. Prenatal maternal C-reactive protein prospectively predicts child executive functioning at ages 4\u20136 years. Dev Psychobiol. 2020;62(8):1111\u201323. https:\/\/doi.org\/10.1002\/dev.21982.","journal-title":"Dev Psychobiol"},{"issue":"3","key":"7_CR76","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1017\/S0033291719003313","volume":"51","author":"SK Hunter","year":"2021","unstructured":"Hunter SK, Hoffman MC, D\u2019Alessandro A, Noonan K, Wyrwa A, Freedman R, et al. Male fetus susceptibility to maternal inflammation: C-reactive protein and brain development. Psychol Med. 2021;51(3):450\u20139. https:\/\/doi.org\/10.1017\/S0033291719003313.","journal-title":"Psychol Med"},{"key":"7_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104797","volume":"120","author":"S Shao","year":"2020","unstructured":"Shao S, Wang J, Huang K, Wang S, Liu H, Wan S, et al. Prenatal pregnancy-related anxiety predicts boys\u2019 ADHD symptoms via placental C-reactive protein. Psychoneuroendocrinology. 2020;120:104797. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104797.","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"7_CR78","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1176\/appi.ajp.2014.13121579","volume":"171","author":"S Canetta","year":"2014","unstructured":"Canetta S, Sourander A, Surcel H-M, Hinkka-Yli-Salom\u00e4ki S, Leivisk\u00e4 J, Kellendonk C, et al. Elevated maternal C-reactive protein and increased risk of schizophrenia in a national birth cohort. Am J Psychiatry. 2014;171(9):960\u20138. https:\/\/doi.org\/10.1176\/appi.ajp.2014.13121579.","journal-title":"Am J Psychiatry"},{"issue":"2","key":"7_CR79","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/mp.2012.197","volume":"19","author":"AS Brown","year":"2014","unstructured":"Brown AS, Sourander A, Hinkka-Yli-Salom\u00e4ki S, McKeague IW, Sundvall J, Surcel H-M. Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry. 2014;19(2):259\u201364. https:\/\/doi.org\/10.1038\/mp.2012.197.","journal-title":"Mol Psychiatry"},{"key":"7_CR80","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jad.2016.08.056","volume":"208","author":"R Chudal","year":"2017","unstructured":"Chudal R, Sourander A, Surcel H-M, Sucksdorff D, Hinkka-Yli-Salom\u00e4ki S, Brown AS. Gestational maternal C\u2014reactive protein and risk of bipolar disorder among young individuals in a Nationwide birth cohort. J Affect Disord. 2017;208:41\u20136. https:\/\/doi.org\/10.1016\/j.jad.2016.08.056.","journal-title":"J Affect Disord"},{"issue":"2","key":"7_CR81","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00787-019-01372-y","volume":"29","author":"R Chudal","year":"2020","unstructured":"Chudal R, Brown AS, Gyllenberg D, Hinkka-Yli-Salom\u00e4ki S, Sucksdorff M, Surcel H-M, et al. Maternal serum C-reactive protein (CRP) and offspring attention deficit hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2020;29(2):239\u201347. https:\/\/doi.org\/10.1007\/s00787-019-01372-y.","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"1","key":"7_CR82","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1056\/NEJMra1906193","volume":"383","author":"AF Carvalho","year":"2020","unstructured":"Carvalho AF, Firth J, Vieta E, Ropper AH. Bipolar disorder. N Engl J Med. 2020;383(1):58\u201366. https:\/\/doi.org\/10.1056\/NEJMra1906193.","journal-title":"N Engl J Med"},{"key":"7_CR83","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.pnpbp.2017.07.026","volume":"79","author":"VS Marshe","year":"2017","unstructured":"Marshe VS, Pira S, Mantere O, Bosche B, Looper KJ, Herrmann N, et al. C-reactive protein and cardiovascular risk in bipolar disorder patients: a systematic review. Prog Neuro-Psychopharmacol Biol Psychiatry. 2017;79:442\u201351. https:\/\/doi.org\/10.1016\/j.pnpbp.2017.07.026.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"7_CR84","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41569-020-00463-7","volume":"18","author":"RE Nielsen","year":"2021","unstructured":"Nielsen RE, Banner J, Jensen SE. Cardiovascular disease in patients with severe mental illness. Nat Rev Cardiol. 2021;18(2):136\u201345. https:\/\/doi.org\/10.1038\/s41569-020-00463-7.","journal-title":"Nat Rev Cardiol"},{"key":"7_CR85","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","volume":"97","author":"M Solmi","year":"2021","unstructured":"Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, et al. Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability. Brain Behav Immun. 2021;97:193\u2013203. https:\/\/doi.org\/10.1016\/j.bbi.2021.07.014.","journal-title":"Brain Behav Immun"},{"issue":"5\u20136","key":"7_CR86","first-page":"366","volume":"67","author":"W Pitchot","year":"2012","unstructured":"Pitchot W, Scantamburlo G, Ansseau M, Souery D. Le trouble bipolaire: une affection bien complexe. Rev M\u00e9d Li\u00e8ge. 2012;67(5\u20136):366\u201373.","journal-title":"Rev M\u00e9d Li\u00e8ge"},{"issue":"10","key":"7_CR87","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1007\/s11920-014-0483-7","volume":"16","author":"D Landgraf","year":"2014","unstructured":"Landgraf D, McCarthy MJ, Welsh DK. Circadian clock and stress interactions in the molecular biology of psychiatric disorders. Curr Psychiatry Rep. 2014;16(10):483. https:\/\/doi.org\/10.1007\/s11920-014-0483-7.","journal-title":"Curr Psychiatry Rep"},{"key":"7_CR88","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.jpsychires.2017.03.018","volume":"92","author":"P Sayana","year":"2017","unstructured":"Sayana P, Colpo GD, Sim\u00f5es LR, Giridharan VV, Teixeira AL, Quevedo J, et al. A systematic review of evidence for the role of inflammatory biomarkers in bipolar patients. J Psychiatr Res. 2017;92:160\u201382. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.03.018.","journal-title":"J Psychiatr Res"},{"key":"7_CR89","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1016\/j.neubiorev.2019.09.025","volume":"107","author":"G Morris","year":"2019","unstructured":"Morris G, Puri BK, Walker AJ, Maes M, Carvalho AF, Bortolasci CC, et al. Shared pathways for neuroprogression and somatoprogression in neuropsychiatric disorders. Neurosci Biobehav Rev. 2019;107:862\u201382. https:\/\/doi.org\/10.1016\/j.neubiorev.2019.09.025.","journal-title":"Neurosci Biobehav Rev"},{"key":"7_CR90","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.bbi.2014.09.021","volume":"43","author":"K Munkholm","year":"2015","unstructured":"Munkholm K, Weikop P, Kessing LV, Vinberg M. Elevated levels of IL-6 and IL-18 in manic and hypomanic states in rapid cycling bipolar disorder patients. Brain Behav Immun. 2015;43:205\u201313. https:\/\/doi.org\/10.1016\/j.bbi.2014.09.021.","journal-title":"Brain Behav Immun"},{"issue":"02","key":"7_CR91","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4088\/JCP.14r09007","volume":"76","author":"AA Darg\u00e9l","year":"2015","unstructured":"Darg\u00e9l AA, Godin O, Kapczinski F, Kupfer DJ, Leboyer M. C-reactive protein alterations in bipolar disorder: a meta-analysis. J Clin Psychiatry. 2015;76(02):142\u201350. https:\/\/doi.org\/10.4088\/JCP.14r09007.","journal-title":"J Clin Psychiatry"},{"issue":"12","key":"7_CR92","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S2215-0366(16)30370-4","volume":"3","author":"BS Fernandes","year":"2016","unstructured":"Fernandes BS, Steiner J, Molendijk ML, Dodd S, Nardin P, Gon\u00e7alves C-A, et al. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. Lancet Psychiatry. 2016;3(12):1147\u201356. https:\/\/doi.org\/10.1016\/S2215-0366(16)30370-4.","journal-title":"Lancet Psychiatry"},{"key":"7_CR93","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.jad.2016.03.040","volume":"197","author":"AS Jacoby","year":"2016","unstructured":"Jacoby AS, Munkholm K, Vinberg M, Pedersen BK, Kessing LV. Cytokines, brain-derived neurotrophic factor and C-reactive protein in bipolar I disorder\u2014results from a prospective study. J Affect Disord. 2016;197:167\u201374. https:\/\/doi.org\/10.1016\/j.jad.2016.03.040.","journal-title":"J Affect Disord"},{"issue":"5","key":"7_CR94","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s00406-007-0797-0","volume":"258","author":"\u00c2B Cunha","year":"2008","unstructured":"Cunha \u00c2B, Andreazza AC, Gomes FA, Frey BN, da Silveira LE, Gon\u00e7alves CA, et al. Investigation of serum high-sensitive C-reactive protein levels across all mood states in bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2008;258(5):300\u20134. https:\/\/doi.org\/10.1007\/s00406-007-0797-0.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"10","key":"7_CR95","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1038\/tp.2013.87","volume":"3","author":"K Becking","year":"2013","unstructured":"Becking K, Boschloo L, Vogelzangs N, Haarman BCM, Riemersma-van der Lek R, Penninx BWJH, et al. The association between immune activation and manic symptoms in patients with a depressive disorder. Transl Psychiatry. 2013;3(10):e314. https:\/\/doi.org\/10.1038\/tp.2013.87.","journal-title":"Transl Psychiatry"},{"issue":"6","key":"7_CR96","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1017\/neu.2021.25","volume":"33","author":"Y Gorgulu","year":"2021","unstructured":"Gorgulu Y, Uluturk MK, Palabiyik O. Comparison of serum BDNF, IL-1\u03b2, IL-6, TNF-\u03b1, CRP and leucocyte levels in unipolar mania and bipolar disorder. Acta Neuropsychiatr. 2021;33(6):317\u201322. https:\/\/doi.org\/10.1017\/neu.2021.25.","journal-title":"Acta Neuropsychiatr"},{"issue":"1","key":"7_CR97","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3109\/15622975.2016.1155746","volume":"18","author":"HH Chang","year":"2017","unstructured":"Chang HH, Wang T-Y, Lee IH, Lee S-Y, Chen KC, Huang S-Y, et al. C-reactive protein: a differential biomarker for major depressive disorder and bipolar II disorder. World J Biol Psychiatry. 2017;18(1):63\u201370. https:\/\/doi.org\/10.3109\/15622975.2016.1155746.","journal-title":"World J Biol Psychiatry"},{"issue":"2","key":"7_CR98","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1192\/bjp.bp.114.150870","volume":"208","author":"MK Wium-Andersen","year":"2016","unstructured":"Wium-Andersen MK, \u00d8rsted DD, Nordestgaard BG. Elevated C-reactive protein and late-onset bipolar disorder in 78 809 individuals from the general population. Br J Psychiatry. 2016;208(2):138\u201345. https:\/\/doi.org\/10.1192\/bjp.bp.114.150870.","journal-title":"Br J Psychiatry"},{"issue":"4","key":"7_CR99","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.pnpbp.2007.02.018","volume":"31","author":"F Dickerson","year":"2007","unstructured":"Dickerson F, Stallings C, Origoni A, Boronow J, Yolken R. Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder. Prog Neuro-Psychopharmacol Biol Psychiatry. 2007;31(4):952\u20135. https:\/\/doi.org\/10.1016\/j.pnpbp.2007.02.018.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"7_CR100","doi-asserted-by":"publisher","first-page":"e66847","DOI":"10.1371\/journal.pone.0066847","volume":"8","author":"S-Y Lee","year":"2013","unstructured":"Lee S-Y, Chen S-L, Chang Y-H, Chen PS, Huang S-Y, Tzeng N-S, et al. Inflammation\u2019s association with metabolic profiles before and after a twelve-week clinical trial in drug-Na\u00efve patients with bipolar II disorder. PLoS One. 2013;8(6):e66847.","journal-title":"PLoS One"},{"issue":"2","key":"7_CR101","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s11126-020-09854-y","volume":"92","author":"G Hamdi","year":"2021","unstructured":"Hamdi G, Ammar HB, Khelifa E, Chaaben AB, Khouadja S, Ayari F, et al. High-sensitive c-reactive protein levels in euthymic bipolar patients: case-control study. Psychiatry Q. 2021;92(2):803\u201311. https:\/\/doi.org\/10.1007\/s11126-020-09854-y.","journal-title":"Psychiatry Q"},{"issue":"1","key":"7_CR102","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s40345-017-0109-1","volume":"6","author":"W Boukouaci","year":"2018","unstructured":"Boukouaci W, Oliveira J, Etain B, Bennabi M, Mariaselvam C, Hamdani N, et al. Association between CRP genetic diversity and bipolar disorder comorbid complications. Int J Bipolar Disord. 2018;6(1):4. https:\/\/doi.org\/10.1186\/s40345-017-0109-1.","journal-title":"Int J Bipolar Disord"},{"issue":"1","key":"7_CR103","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s40345-019-0162-z","volume":"7","author":"A-K Evers","year":"2019","unstructured":"Evers A-K, Veeh J, McNeill R, Reif A, Kittel-Schneider S. C-reactive protein concentration in bipolar disorder: association with genetic variants. Int J Bipolar Disord. 2019;7(1):26. https:\/\/doi.org\/10.1186\/s40345-019-0162-z.","journal-title":"Int J Bipolar Disord"},{"key":"7_CR104","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.schres.2017.04.015","volume":"192","author":"B Misiak","year":"2018","unstructured":"Misiak B, Sta\u0144czykiewicz B, Kotowicz K, Rybakowski JK, Samochowiec J, Frydecka D. Cytokines and C-reactive protein alterations with respect to cognitive impairment in schizophrenia and bipolar disorder: a systematic review. Schizophr Res. 2018;192:16\u201329. https:\/\/doi.org\/10.1016\/j.schres.2017.04.015.","journal-title":"Schizophr Res"},{"issue":"1","key":"7_CR105","doi-asserted-by":"publisher","DOI":"10.1192\/j.eurpsy.2021.6","volume":"64","author":"DC Milton","year":"2021","unstructured":"Milton DC, Ward J, Ward E, Lyall DM, Strawbridge RJ, Smith DJ, et al. The association between C-reactive protein, mood disorder, and cognitive function in UK biobank. Eur Psychiatry. 2021;64(1):e14. https:\/\/doi.org\/10.1192\/j.eurpsy.2021.6.","journal-title":"Eur Psychiatry"},{"issue":"8","key":"7_CR106","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1038\/s41380-019-0591-1","volume":"26","author":"CE Millett","year":"2021","unstructured":"Millett CE, Perez-Rodriguez M, Shanahan M, Larsen E, Yamamoto HS, Bukowski C, et al. C-reactive protein is associated with cognitive performance in a large cohort of euthymic patients with bipolar disorder. Mol Psychiatry. 2021;26(8):4096\u2013105. https:\/\/doi.org\/10.1038\/s41380-019-0591-1.","journal-title":"Mol Psychiatry"},{"issue":"1","key":"7_CR107","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1124\/pr.111.005512","volume":"65","author":"C-T Chiu","year":"2013","unstructured":"Chiu C-T, Wang Z, Hunsberger JG, Chuang D-M. Therapeutic potential of mood stabilizers lithium and Valproic acid: beyond bipolar disorder. Sibley DR, curatore. Pharmacol Rev. 2013;65(1):105\u201342. https:\/\/doi.org\/10.1124\/pr.111.005512.","journal-title":"Pharmacol Rev"},{"key":"7_CR108","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.bbi.2018.08.009","volume":"73","author":"CL Raison","year":"2018","unstructured":"Raison CL, Pikalov A, Siu C, Tsai J, Koblan K, Loebel A. C-reactive protein and response to lurasidone in patients with bipolar depression. Brain Behav Immun. 2018;73:717\u201324. https:\/\/doi.org\/10.1016\/j.bbi.2018.08.009.","journal-title":"Brain Behav Immun"},{"key":"7_CR109","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.npbr.2019.07.007","volume":"33","author":"JG Fiedorowicz","year":"2019","unstructured":"Fiedorowicz JG, Cyranowski JM, Liu Z, Swartz HA. Changes in inflammation with treatment for bipolar II depression: pilot trial data on differential effects of psychotherapy and medication. Neurol Psychiatry Brain Res. 2019;33:112\u20138. https:\/\/doi.org\/10.1016\/j.npbr.2019.07.007.","journal-title":"Neurol Psychiatry Brain Res"},{"key":"7_CR110","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.bbi.2019.12.010","volume":"84","author":"CL Raison","year":"2020","unstructured":"Raison CL, Siu C, Pikalov A, Tocco M, Loebel A. C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: results from a placebo-controlled trial. Brain Behav Immun. 2020;84:269\u201374. https:\/\/doi.org\/10.1016\/j.bbi.2019.12.010.","journal-title":"Brain Behav Immun"},{"issue":"8","key":"7_CR111","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1001\/jamapsychiatry.2019.0779","volume":"76","author":"RS McIntyre","year":"2019","unstructured":"McIntyre RS, Subramaniapillai M, Lee Y, Pan Z, Carmona NE, Shekotikhina M, et al. Efficacy of adjunctive infliximab vs placebo in the treatment of adults with bipolar I\/II depression: a randomized clinical trial. JAMA Psychiat. 2019;76(8):783. https:\/\/doi.org\/10.1001\/jamapsychiatry.2019.0779.","journal-title":"JAMA Psychiat"},{"issue":"10","key":"7_CR112","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1016\/j.euroneuro.2015.05.003","volume":"25","author":"P Courtet","year":"2015","unstructured":"Courtet P, Jaussent I, Genty C, Dupuy AM, Guillaume S, Ducasse D, et al. Increased CRP levels may be a trait marker of suicidal attempt. Eur Neuropsychopharmacol. 2015;25(10):1824\u201331. https:\/\/doi.org\/10.1016\/j.euroneuro.2015.05.003.","journal-title":"Eur Neuropsychopharmacol"},{"key":"7_CR113","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2020.113320","volume":"292","author":"X Chen","year":"2020","unstructured":"Chen X, Pu J, Liu Y, Tian L, Chen Y, Gui S, et al. Increased C-reactive protein concentrations were associated with suicidal behavior in patients with depressive disorders: a meta-analysis. Psychiatry Res. 2020;292:113320. https:\/\/doi.org\/10.1016\/j.psychres.2020.113320.","journal-title":"Psychiatry Res"},{"issue":"9","key":"7_CR114","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1001\/jamapsychiatry.2016.1805","volume":"73","author":"GD Batty","year":"2016","unstructured":"Batty GD, Bell S, Stamatakis E, Kivim\u00e4ki M. Association of Systemic Inflammation with Risk of completed suicide in the general population. JAMA Psychiat. 2016;73(9):993. https:\/\/doi.org\/10.1001\/jamapsychiatry.2016.1805.","journal-title":"JAMA Psychiat"},{"issue":"9","key":"7_CR115","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.euroneuro.2017.06.010","volume":"27","author":"RJ Park","year":"2017","unstructured":"Park RJ, Kim YH. Association between high sensitivity CRP and suicidal ideation in the Korean general population. Eur Neuropsychopharmacol. 2017;27(9):885\u201391. https:\/\/doi.org\/10.1016\/j.euroneuro.2017.06.010.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"4","key":"7_CR116","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.bbi.2005.11.002","volume":"20","author":"JE Graham","year":"2006","unstructured":"Graham JE, Robles TF, Kiecolt-Glaser JK, Malarkey WB, Bissell MG, Glaser R. Hostility and pain are related to inflammation in older adults. Brain Behav Immun. 2006;20(4):389\u2013400. https:\/\/doi.org\/10.1016\/j.bbi.2005.11.002.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"7_CR117","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1001\/jamapsychiatry.2013.3297","volume":"71","author":"EF Coccaro","year":"2014","unstructured":"Coccaro EF, Lee R, Coussons-Read M. Elevated plasma inflammatory markers in individuals with intermittent explosive disorder and correlation with aggression in humans. JAMA Psychiat. 2014;71(2):158. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.3297.","journal-title":"JAMA Psychiat"},{"issue":"2","key":"7_CR118","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s00702-014-1263-6","volume":"122","author":"EF Coccaro","year":"2015","unstructured":"Coccaro EF, Lee R, Coussons-Read M. Cerebrospinal fluid and plasma C-reactive protein and aggression in personality-disordered subjects: a pilot study. J Neural Transm. 2015;122(2):321\u20136. https:\/\/doi.org\/10.1007\/s00702-014-1263-6.","journal-title":"J Neural Transm"},{"issue":"2","key":"7_CR119","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1111\/j.1601-183X.2008.00461.x","volume":"8","author":"P Suchankova","year":"2009","unstructured":"Suchankova P, Henningsson S, Baghaei F, Rosmond R, Holm G, Ekman A. Genetic variability within the innate immune system influences personality traits in women. Genes Brain Behav. 2009;8(2):212\u20137. https:\/\/doi.org\/10.1111\/j.1601-183X.2008.00461.x.","journal-title":"Genes Brain Behav"},{"issue":"2","key":"7_CR120","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/YPG.0b013e32835d71b6","volume":"23","author":"P Suchankova","year":"2013","unstructured":"Suchankova P, Holm G, Tr\u00e4skman-Bendz L, Brundin L, Ekman A. The +1444C>T polymorphism in the CRP gene: a study on personality traits and suicidal behaviour. Psychiatr Genet. 2013;23(2):70\u20136. https:\/\/doi.org\/10.1097\/YPG.0b013e32835d71b6.","journal-title":"Psychiatr Genet"},{"key":"7_CR121","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.3389\/fimmu.2018.02230","volume":"9","author":"I Jacomb","year":"2018","unstructured":"Jacomb I, Stanton C, Vasudevan R, Powell H, O\u2019Donnell M, Lenroot R, et al. C-reactive protein: higher during acute psychotic episodes and related to cortical thickness in schizophrenia and healthy controls. Front Immunol. 2018;9:2230. https:\/\/doi.org\/10.3389\/fimmu.2018.02230.","journal-title":"Front Immunol"},{"issue":"7321","key":"7_CR122","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature09563","volume":"468","author":"J van Os","year":"2010","unstructured":"van Os J, Kenis G, Rutten BPF. The environment and schizophrenia. Nature. 2010;468(7321):203\u201312. https:\/\/doi.org\/10.1038\/nature09563.","journal-title":"Nature"},{"issue":"1\u20133","key":"7_CR123","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.schres.2015.09.021","volume":"169","author":"CA Castellani","year":"2015","unstructured":"Castellani CA, Melka MG, Gui JL, O\u2019Reilly RL, Singh SM. Integration of DNA sequence and DNA methylation changes in monozygotic twin pairs discordant for schizophrenia. Schizophr Res. 2015;169(1\u20133):433\u201340. https:\/\/doi.org\/10.1016\/j.schres.2015.09.021.","journal-title":"Schizophr Res"},{"key":"7_CR124","doi-asserted-by":"publisher","unstructured":"van de Leemput J, Hess JL, Glatt SJ, Tsuang MT. Genetics of schizophrenia. In: Advances in genetics. Amsterdam: Elsevier; 2016. https:\/\/doi.org\/10.1016\/bs.adgen.2016.08.001.","DOI":"10.1016\/bs.adgen.2016.08.001"},{"issue":"2\u20133","key":"7_CR125","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1159\/000356538","volume":"21","author":"N M\u00fcller","year":"2014","unstructured":"M\u00fcller N. Immunology of schizophrenia. Neuroimmunomodulation. 2014;21(2\u20133):109\u201316. https:\/\/doi.org\/10.1159\/000356538.","journal-title":"Neuroimmunomodulation"},{"issue":"12","key":"7_CR126","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1017\/S0033291719001685","volume":"49","author":"E Bora","year":"2019","unstructured":"Bora E. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis. Psychol Med. 2019;49(12):1971\u20139. https:\/\/doi.org\/10.1017\/S0033291719001685.","journal-title":"Psychol Med"},{"key":"7_CR127","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/7854_2018_88","volume":"44","author":"R Upthegrove","year":"2020","unstructured":"Upthegrove R, Khandaker GM. Cytokines, oxidative stress and cellular markers of inflammation in schizophrenia. Curr Top Behav Neurosci. 2020;44:49\u201366. https:\/\/doi.org\/10.1007\/7854_2018_88.","journal-title":"Curr Top Behav Neurosci"},{"issue":"4","key":"7_CR128","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1600-0447.1995.tb09581.x","volume":"92","author":"B Spivak","year":"1995","unstructured":"Spivak B, Radwan M, Bartur P, Mester R, Weizman A. Antinuclear autoantibodies in chronic schizophrenia. Acta Psychiatr Scand. 1995;92(4):266\u20139. https:\/\/doi.org\/10.1111\/j.1600-0447.1995.tb09581.x.","journal-title":"Acta Psychiatr Scand"},{"issue":"8","key":"7_CR129","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63(8):801\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2007.09.024.","journal-title":"Biol Psychiatry"},{"key":"7_CR130","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2010\/289645","volume":"2010","author":"R Monteiro","year":"2010","unstructured":"Monteiro R, Azevedo I. Chronic inflammation in obesity and the metabolic syndrome. Mediat Inflamm. 2010;2010:1\u201310. https:\/\/doi.org\/10.1155\/2010\/289645.","journal-title":"Mediat Inflamm"},{"issue":"5","key":"7_CR131","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1192\/bjp.bp.111.092098","volume":"200","author":"S-J Chen","year":"2012","unstructured":"Chen S-J, Chao Y-L, Chen C-Y, Chang C-M, Wu EC-H, Wu C-S, et al. Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study. Br J Psychiatry. 2012;200(5):374\u201380. https:\/\/doi.org\/10.1192\/bjp.bp.111.092098.","journal-title":"Br J Psychiatry"},{"issue":"2","key":"7_CR132","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","volume":"171","author":"ME Benros","year":"2014","unstructured":"Benros ME, Pedersen MG, Rasmussen H, Eaton WW, Nordentoft M, Mortensen PB. A Nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis. Am J Psychiatry. 2014;171(2):218\u201326. https:\/\/doi.org\/10.1176\/appi.ajp.2013.13010086.","journal-title":"Am J Psychiatry"},{"issue":"1","key":"7_CR133","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/s12974-018-1096-6","volume":"15","author":"M Juncal-Ruiz","year":"2018","unstructured":"Juncal-Ruiz M, Riesco-D\u00e1vila L, de la Foz VO-G, Ram\u00edrez-Bonilla M, Mart\u00ednez-Garc\u00eda O, Irure-Ventura J, et al. The effect of excess weight on circulating inflammatory cytokines in drug-na\u00efve first-episode psychosis individuals. J Neuroinflammation. 2018;15(1):63. https:\/\/doi.org\/10.1186\/s12974-018-1096-6.","journal-title":"J Neuroinflammation"},{"issue":"2\u20133","key":"7_CR134","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1159\/000356536","volume":"21","author":"Z Zajkowska","year":"2014","unstructured":"Zajkowska Z, Mondelli V. First-episode psychosis: an inflammatory state? Neuroimmunomodulation. 2014;21(2\u20133):102\u20138. https:\/\/doi.org\/10.1159\/000356536.","journal-title":"Neuroimmunomodulation"},{"issue":"2","key":"7_CR135","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1093\/schbul\/sbu099","volume":"41","author":"DO Perkins","year":"2015","unstructured":"Perkins DO, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, et al. Towards a psychosis risk blood diagnostic for persons experiencing high-risk symptoms: preliminary results from the NAPLS project. Schizophr Bull. 2015;41(2):419\u201328. https:\/\/doi.org\/10.1093\/schbul\/sbu099.","journal-title":"Schizophr Bull"},{"key":"7_CR136","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","volume":"59","author":"SA Metcalf","year":"2017","unstructured":"Metcalf SA, Jones PB, Nordstrom T, Timonen M, M\u00e4ki P, Miettunen J, et al. Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study. Brain Behav Immun. 2017;59:253\u20139.","journal-title":"Brain Behav Immun"},{"key":"7_CR137","doi-asserted-by":"publisher","first-page":"672","DOI":"10.3389\/fpsyt.2020.00672","volume":"11","author":"EJ Reponen","year":"2020","unstructured":"Reponen EJ, Dieset I, Tesli M, M\u00f8rch RH, Aas M, Vedal TSJ, et al. Atherogenic lipid ratios related to myeloperoxidase and C-reactive protein levels in psychotic disorders. Front Psych. 2020;11:672. https:\/\/doi.org\/10.3389\/fpsyt.2020.00672.","journal-title":"Front Psych"},{"issue":"1","key":"7_CR138","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.psychres.2011.05.010","volume":"190","author":"MH Fawzi","year":"2011","unstructured":"Fawzi MH, Fawzi MM, Fawzi MM, Said NS. C-reactive protein serum level in drug-free male Egyptian patients with schizophrenia. Psychiatry Res. 2011;190(1):91\u20137. https:\/\/doi.org\/10.1016\/j.psychres.2011.05.010.","journal-title":"Psychiatry Res"},{"key":"7_CR139","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.pnpbp.2018.04.006","volume":"86","author":"EJ Liemburg","year":"2018","unstructured":"Liemburg EJ, Nolte IM, Klein HC, Knegtering H. Relation of inflammatory markers with symptoms of psychotic disorders: a large cohort study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2018;86:89\u201394. https:\/\/doi.org\/10.1016\/j.pnpbp.2018.04.006.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"6","key":"7_CR140","doi-asserted-by":"publisher","first-page":"e1001976","DOI":"10.1371\/journal.pmed.1001976","volume":"13","author":"P BramP","year":"2016","unstructured":"BramP P, Abbasi A, Wong A, Vaez A, Nolte I, Franceschini N, et al. Investigating the causal relationship of C-reactive protein with 32 complex somatic and psychiatric outcomes: a large-scale cross-consortium Mendelian randomization study. PLoS Med. 2016;13(6):e1001976. https:\/\/doi.org\/10.1371\/journal.pmed.1001976.","journal-title":"PLoS Med"},{"issue":"1","key":"7_CR141","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.schres.2015.03.018","volume":"165","author":"J-A Micoulaud-Franchi","year":"2015","unstructured":"Micoulaud-Franchi J-A, Faugere M, Boyer L, Fond G, Richieri R, Faget C, et al. Elevated C-reactive protein is associated with sensory gating deficit in schizophrenia. Schizophr Res. 2015;165(1):94\u20136. https:\/\/doi.org\/10.1016\/j.schres.2015.03.018.","journal-title":"Schizophr Res"},{"issue":"5","key":"7_CR142","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/schbul\/sbw029","volume":"42","author":"E Bulzacka","year":"2016","unstructured":"Bulzacka E, Boyer L, Sch\u00fcrhoff F, Godin O, Berna F, Brunel L, et al. Chronic peripheral inflammation is associated with cognitive impairment in schizophrenia: results from the multicentric FACE-SZ dataset. Schizophr Bull. 2016;42(5):1290\u2013302. https:\/\/doi.org\/10.1093\/schbul\/sbw029.","journal-title":"Schizophr Bull"},{"key":"7_CR143","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.bbi.2020.05.017","volume":"88","author":"JP-C Chang","year":"2020","unstructured":"Chang JP-C, Mondelli V, Satyanarayanan SK, Chiang Y-J, Chen H-T, Su K-P, et al. Cortisol, inflammatory biomarkers and neurotrophins in children and adolescents with attention deficit hyperactivity disorder (ADHD) in Taiwan. Brain Behav Immun. 2020;88:105\u201313. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.017.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"7_CR144","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1017\/neu.2018.25","volume":"31","author":"F Fathian","year":"2019","unstructured":"Fathian F, L\u00f8berg E-M, Gjestad R, Steen VM, Kroken RA, J\u00f8rgensen HA, et al. Associations between C-reactive protein levels and cognition during the first 6 months after acute psychosis. Acta Neuropsychiatr. 2019;31(1):36\u201345. https:\/\/doi.org\/10.1017\/neu.2018.25.","journal-title":"Acta Neuropsychiatr"},{"key":"7_CR145","doi-asserted-by":"publisher","DOI":"10.1016\/j.comppsych.2020.152195","volume":"102","author":"BJ Miller","year":"2020","unstructured":"Miller BJ, Pikalov A, Siu CO, Tocco M, Tsai J, Harvey PD, et al. Association of C-reactive protein and metabolic risk with cognitive effects of lurasidone in patients with schizophrenia. Compr Psychiatry. 2020;102:152195. https:\/\/doi.org\/10.1016\/j.comppsych.2020.152195.","journal-title":"Compr Psychiatry"},{"issue":"7","key":"7_CR146","doi-asserted-by":"publisher","first-page":"940","DOI":"10.4088\/jcp.v65n0710","volume":"65","author":"XY Zhang","year":"2004","unstructured":"Zhang XY, Zhou DF, Cao LY, Zhang PY, Wu GY, Shen YC. Changes in serum Interleukin-2, \u22126, and \u22128 levels before and during treatment with Risperidone and haloperidol: relationship to outcome in schizophrenia. J Clin Psychiatry. 2004;65(7):940\u20137. https:\/\/doi.org\/10.4088\/jcp.v65n0710.","journal-title":"J Clin Psychiatry"},{"issue":"1\u20133","key":"7_CR147","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.schres.2013.10.011","volume":"151","author":"V Tourjman","year":"2013","unstructured":"Tourjman V, Kouassi \u00c9, Kou\u00e9 M-\u00c8, Rocchetti M, Fortin-Fournier S, Fusar-Poli P, et al. Antipsychotics\u2019 effects on blood levels of cytokines in schizophrenia: a meta-analysis. Schizophr Res. 2013;151(1\u20133):43\u20137. https:\/\/doi.org\/10.1016\/j.schres.2013.10.011.","journal-title":"Schizophr Res"},{"issue":"6","key":"7_CR148","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00406-017-0847-1","volume":"268","author":"G Fond","year":"2018","unstructured":"Fond G, Resseguier N, Sch\u00fcrhoff F, Godin O, Andrianarisoa M, et al. The FACE-SZ (FondaMental academic centers of expertise for schizophrenia) group. Relationships between low-grade peripheral inflammation and psychotropic drugs in schizophrenia: results from the national FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci. 2018;268(6):541\u201353. https:\/\/doi.org\/10.1007\/s00406-017-0847-1.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"8","key":"7_CR149","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00406-018-0908-0","volume":"269","author":"G Fond","year":"2019","unstructured":"Fond G, Godin O, Boyer L, Berna F, Andrianarisoa M, et al. The FACE-SZ (FondaMental academic centers of expertise for schizophrenia) group. Chronic low-grade peripheral inflammation is associated with ultra resistant schizophrenia. Results from the FACE-SZ cohort. Eur Arch Psychiatry Clin Neurosci. 2019;269(8):985\u201392. https:\/\/doi.org\/10.1007\/s00406-018-0908-0.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"04","key":"7_CR150","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4088\/JCP.10r06823","volume":"73","author":"IE Sommer","year":"2012","unstructured":"Sommer IE, de Witte L, Begemann M, Kahn RS. Nonsteroidal anti-inflammatory drugs in schizophrenia: ready for practice or a good start? A Meta-Analysis. J Clin Psychiatry. 2012;73(04):414\u20139. https:\/\/doi.org\/10.4088\/JCP.10r06823.","journal-title":"J Clin Psychiatry"},{"key":"7_CR151","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/3476240","volume":"2016","author":"S Marini","year":"2016","unstructured":"Marini S, De Berardis D, Vellante F, Santacroce R, Orsolini L, Valchera A, et al. Celecoxib adjunctive treatment to antipsychotics in schizophrenia: a review of randomized clinical add-on trials. Mediat Inflamm. 2016;2016:1\u20138. https:\/\/doi.org\/10.1155\/2016\/3476240.","journal-title":"Mediat Inflamm"},{"issue":"14","key":"7_CR152","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1017\/S0033291719001995","volume":"49","author":"N \u00c7akici","year":"2019","unstructured":"\u00c7akici N, van Beveren NJM, Judge-Hundal G, Koola MM, Sommer IEC. An update on the efficacy of anti-inflammatory agents for patients with schizophrenia: a meta-analysis. Psychol Med. 2019;49(14):2307\u201319. https:\/\/doi.org\/10.1017\/S0033291719001995.","journal-title":"Psychol Med"},{"key":"7_CR153","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2013","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC: American Psychiatric Association; 2013.","edition":"5"},{"issue":"2","key":"7_CR154","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.atherosclerosis.2005.06.001","volume":"185","author":"C Pitsavos","year":"2006","unstructured":"Pitsavos C, Panagiotakos DB, Papageorgiou C, Tsetsekou E, Soldatos C, Stefanadis C. Anxiety in relation to inflammation and coagulation markers, among healthy adults: the ATTICA study. Atherosclerosis. 2006;185(2):320\u20136. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2005.06.001.","journal-title":"Atherosclerosis"},{"issue":"12","key":"7_CR155","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1017\/S0033291712000554","volume":"42","author":"WE Copeland","year":"2012","unstructured":"Copeland WE, Shanahan L, Worthman C, Angold A, Costello EJ. Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. Psychol Med. 2012;42(12):2641\u201350. https:\/\/doi.org\/10.1017\/S0033291712000554.","journal-title":"Psychol Med"},{"issue":"4","key":"7_CR156","doi-asserted-by":"publisher","first-page":"e249","DOI":"10.1038\/tp.2013.27","volume":"3","author":"N Vogelzangs","year":"2013","unstructured":"Vogelzangs N, Beekman ATF, de Jonge P, Penninx BWJH. Anxiety disorders and inflammation in a large adult cohort. Transl Psychiatry. 2013;3(4):e249. https:\/\/doi.org\/10.1038\/tp.2013.27.","journal-title":"Transl Psychiatry"},{"issue":"4","key":"7_CR157","doi-asserted-by":"publisher","first-page":"e0123757","DOI":"10.1371\/journal.pone.0123757","volume":"10","author":"E-YN Wagner","year":"2015","unstructured":"Wagner E-YN, Wagner JT, Glaus J, Vandeleur CL, Castelao E, Strippoli M-PF, et al. Evidence for chronic low-grade systemic inflammation in individuals with agoraphobia from a population-based prospective study. PLoS One. 2015;10(4):e0123757. https:\/\/doi.org\/10.1371\/journal.pone.0123757.","journal-title":"PLoS One"},{"issue":"7","key":"7_CR158","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.1016\/j.bbi.2010.03.003","volume":"24","author":"A O\u2019Donovan","year":"2010","unstructured":"O\u2019Donovan A, Hughes BM, Slavich GM, Lynch L, Cronin M-T, O\u2019Farrelly C, et al. Clinical anxiety, cortisol and interleukin-6: evidence for specificity in emotion\u2013biology relationships. Brain Behav Immun. 2010;24(7):1074\u20137. https:\/\/doi.org\/10.1016\/j.bbi.2010.03.003.","journal-title":"Brain Behav Immun"},{"issue":"7","key":"7_CR159","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027925","volume":"9","author":"H Costello","year":"2019","unstructured":"Costello H, Gould RL, Abrol E, Howard R. Systematic review and meta-analysis of the association between peripheral inflammatory cytokines and generalised anxiety disorder. BMJ Open. 2019;9(7):e027925. https:\/\/doi.org\/10.1136\/bmjopen-2018-027925.","journal-title":"BMJ Open"},{"issue":"1","key":"7_CR160","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/13811118.2015.1004485","volume":"21","author":"D De Berardis","year":"2017","unstructured":"De Berardis D, Serroni N, Campanella D, Marini S, Rapini G, Valchera A, et al. Alexithymia, suicide ideation, C-reactive protein, and serum lipid levels among outpatients with generalized anxiety disorder. Arch Suicide Res. 2017;21(1):100\u201312. https:\/\/doi.org\/10.1080\/13811118.2015.1004485.","journal-title":"Arch Suicide Res"},{"key":"7_CR161","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.bbi.2017.11.020","volume":"4","author":"GM Khandaker","year":"2016","unstructured":"Khandaker GM, Zammit S, Lewis G, Jones PB. Association between serum C-reactive protein and DSM-IV generalized anxiety disorder in adolescence: findings from the ALSPAC cohort. Neurobiol Stress. 2016;4:55\u201361. https:\/\/doi.org\/10.1016\/j.bbi.2017.11.020.","journal-title":"Neurobiol Stress"},{"key":"7_CR162","doi-asserted-by":"publisher","first-page":"123","DOI":"10.31254\/jmr.2018.4304","volume":"4","author":"S Nayek","year":"2018","unstructured":"Nayek S, Ghosh S. A comparative study of serum C-reactive protein in patients with generalised anxiety disorder and depression. J Med Res. 2018;4:123\u201331.","journal-title":"J Med Res"},{"key":"7_CR163","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.jad.2017.08.082","volume":"225","author":"Z Tang","year":"2018","unstructured":"Tang Z, Ye G, Chen X, Pan M, Fu J, Fu T, et al. Peripheral proinflammatory cytokines in Chinese patients with generalised anxiety disorder. J Affect Disord. 2018;225:593\u20138. https:\/\/doi.org\/10.1016\/j.jad.2017.08.082.","journal-title":"J Affect Disord"},{"issue":"S1","key":"7_CR164","first-page":"1","volume":"25","author":"J Korkeila","year":"2010","unstructured":"Korkeila J, Runsten S, Ollikainen S, Korkeila K. PW01-161\u2014generalized anxiety disorder and immunity markers in a stratified population sample. Eur Psychiatry. 2010;25(S1):1\u20131.","journal-title":"Eur Psychiatry"},{"issue":"6","key":"7_CR165","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1080\/15622975.2018.1433325","volume":"19","author":"PJW Naud\u00e9","year":"2018","unstructured":"Naud\u00e9 PJW, Roest AM, Stein DJ, de Jonge P, Doornbos B. Anxiety disorders and CRP in a population cohort study with 54,326 participants: the life lines study. World J Biol Psychiatry. 2018;19(6):461\u201370. https:\/\/doi.org\/10.1080\/15622975.2018.1433325.","journal-title":"World J Biol Psychiatry"},{"issue":"9-10","key":"7_CR166","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1111\/ejn.15031","volume":"55","author":"SF Friend","year":"2020","unstructured":"Friend SF, Nachnani R, Powell SB, Risbrough VB. C-reactive protein: marker of risk for post-traumatic stress disorder and its potential for a mechanistic role in trauma response and recovery. Eur J Neurosci. 2020;55(9-10):2297\u2013310. https:\/\/doi.org\/10.1111\/ejn.15031.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"7_CR167","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1365-2249.2007.03356.x","volume":"148","author":"B Afzali","year":"2007","unstructured":"Afzali B, Lombardi G, Lechler RI, Lord GM. The role of T helper 17 (Th17) and regulatory T cells (Treg) in Human organ transplantation and autoimmune disease: role of Th17 and Tregs in Human disease. Clin Exp Immunol. 2007;148(1):32\u201346. https:\/\/doi.org\/10.1111\/j.1365-2249.2007.03356.x.","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"7_CR168","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1016\/j.bbi.2009.07.003","volume":"23","author":"A Sommershof","year":"2009","unstructured":"Sommershof A, Aichinger H, Engler H, Adenauer H, Catani C, Boneberg E-M, et al. Substantial reduction of na\u00efve and regulatory T cells following traumatic stress. Brain Behav Immun. 2009;23(8):1117\u201324. https:\/\/doi.org\/10.1016\/j.bbi.2009.07.003.","journal-title":"Brain Behav Immun"},{"issue":"5","key":"7_CR169","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2015.67","volume":"21","author":"D Baumeister","year":"2016","unstructured":"Baumeister D, Akhtar R, Ciufolini S, Pariante CM, Mondelli V. Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-\u03b1. Mol Psychiatry. 2016;21(5):642\u20139. https:\/\/doi.org\/10.1038\/mp.2015.67.","journal-title":"Mol Psychiatry"},{"issue":"7","key":"7_CR170","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1007\/s00406-021-01245-z","volume":"271","author":"KF Fischer","year":"2021","unstructured":"Fischer KF, Simon MS, Elsner J, Dobmeier J, Dorr J, Blei L, et al. Assessing the links between childhood trauma, C-reactive protein and response to antidepressant treatment in patients with affective disorders. Eur Arch Psychiatry Clin Neurosci. 2021;271(7):1331\u201341. https:\/\/doi.org\/10.1007\/s00406-021-01245-z.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"11","key":"7_CR171","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.psyneuen.2013.05.007","volume":"38","author":"RE Lacey","year":"2013","unstructured":"Lacey RE, Kumari M, McMunn A. Parental separation in childhood and adult inflammation: the importance of material and psychosocial pathways. Psychoneuroendocrinology. 2013;38(11):2476\u201384. https:\/\/doi.org\/10.1016\/j.psyneuen.2013.05.007.","journal-title":"Psychoneuroendocrinology"},{"key":"7_CR172","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbi.2012.08.010","volume":"31","author":"TW McDade","year":"2013","unstructured":"McDade TW, Hoke M, Borja JB, Adair LS, Kuzawa C. Do environments in infancy moderate the association between stress and inflammation in adulthood? Initial evidence from a birth cohort in the Philippines. Brain Behav Immun. 2013;31:23\u201330. https:\/\/doi.org\/10.1016\/j.bbi.2012.08.010.","journal-title":"Brain Behav Immun"},{"key":"7_CR173","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.comppsych.2019.06.007","volume":"93","author":"A Powers","year":"2019","unstructured":"Powers A, Dixon HD, Conneely K, Gluck R, Munoz A, Rochat C, et al. The differential effects of PTSD, MDD, and dissociation on CRP in trauma-exposed women. Compr Psychiatry. 2019;93:33\u201340. https:\/\/doi.org\/10.1016\/j.comppsych.2019.06.007.","journal-title":"Compr Psychiatry"},{"issue":"1\u20132","key":"7_CR174","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cccn.2003.12.019","volume":"342","author":"HP S\u00f6ndergaard","year":"2004","unstructured":"S\u00f6ndergaard HP, Hansson L-O, Theorell T. The inflammatory markers C-reactive protein and serum amyloid a in refugees with and without posttraumatic stress disorder. Clin Chim Acta. 2004;342(1\u20132):93\u20138. https:\/\/doi.org\/10.1016\/j.cccn.2003.12.019.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"7_CR175","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.cyto.2011.03.025","volume":"55","author":"EC McCanlies","year":"2011","unstructured":"McCanlies EC, Araia SK, Joseph PN, Mnatsakanova A, Andrew ME, Burchfiel CM, et al. C-reactive protein, Interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine. 2011;55(1):74\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2011.03.025.","journal-title":"Cytokine"},{"issue":"2","key":"7_CR176","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.cyto.2013.04.030","volume":"63","author":"NM Heath","year":"2013","unstructured":"Heath NM, Chesney SA, Gerhart JI, Goldsmith RE, Luborsky JL, Stevens NR, et al. Interpersonal violence, PTSD, and inflammation: potential psychogenic pathways to higher C-reactive protein levels. Cytokine. 2013;63(2):172\u20138. https:\/\/doi.org\/10.1016\/j.cyto.2013.04.030.","journal-title":"Cytokine"},{"issue":"4","key":"7_CR177","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","volume":"71","author":"SA Eraly","year":"2014","unstructured":"Eraly SA, Nievergelt CM, Maihofer AX, Barkauskas DA, Biswas N, Agorastos A, et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiat. 2014;71(4):423. https:\/\/doi.org\/10.1001\/jamapsychiatry.2013.4374.","journal-title":"JAMA Psychiat"},{"issue":"11","key":"7_CR178","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S2215-0366(15)00309-0","volume":"2","author":"IC Passos","year":"2015","unstructured":"Passos IC, Vasconcelos-Moreno MP, Costa LG, Kunz M, Brietzke E, Quevedo J, et al. Inflammatory markers in post-traumatic stress disorder: a systematic review, meta-analysis, and meta-regression. Lancet Psychiatry. 2015;2(11):1002\u201312.","journal-title":"Lancet Psychiatry"},{"key":"7_CR179","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.jpsychires.2017.01.007","volume":"89","author":"RL Rosen","year":"2017","unstructured":"Rosen RL, Levy-Carrick N, Reibman J, Xu N, Shao Y, Liu M, et al. Elevated C-reactive protein and posttraumatic stress pathology among survivors of the 9\/11 world trade center attacks. J Psychiatr Res. 2017;89:14\u201321.","journal-title":"J Psychiatr Res"},{"key":"7_CR180","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.jad.2020.02.044","volume":"268","author":"J-J Yang","year":"2020","unstructured":"Yang J-J, Jiang W. Immune biomarkers alterations in post-traumatic stress disorder: a systematic review and meta-analysis. J Affect Disord. 2020;268:39\u201346. https:\/\/doi.org\/10.1016\/j.jad.2020.02.044.","journal-title":"J Affect Disord"},{"issue":"4","key":"7_CR181","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/cyto.2000.0825","volume":"13","author":"RJ Miller","year":"2001","unstructured":"Miller RJ, Sutherland AG, Hutchison JD, Alexander DA. C-reactive protein and interleukin6 receptor in post-traumatic stress disorder: a pilot study. Cytokine. 2001;13(4):253\u20135. https:\/\/doi.org\/10.1006\/cyto.2000.0825.","journal-title":"Cytokine"},{"key":"7_CR182","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbi.2017.11.013","volume":"69","author":"JA Sumner","year":"2018","unstructured":"Sumner JA, Chen Q, Roberts AL, Winning A, Rimm EB, Gilsanz P, et al. Posttraumatic stress disorder onset and inflammatory and endothelial function biomarkers in women. Brain Behav Immun. 2018;69:203\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2017.11.013.","journal-title":"Brain Behav Immun"},{"key":"7_CR183","doi-asserted-by":"publisher","DOI":"10.1016\/j.psyneuen.2020.104656","volume":"117","author":"EJ Wolf","year":"2020","unstructured":"Wolf EJ, Logue MW, Zhao X, Daskalakis NP, Morrison FG, Escarfulleri S, et al. PTSD and the klotho longevity gene: evaluation of longitudinal effects on inflammation via DNA methylation. Psychoneuroendocrinology. 2020;117:104656. https:\/\/doi.org\/10.1016\/j.psyneuen.2020.104656.","journal-title":"Psychoneuroendocrinology"},{"issue":"4","key":"7_CR184","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1176\/appi.ajp.2014.14020263","volume":"172","author":"V Michopoulos","year":"2015","unstructured":"Michopoulos V, Rothbaum AO, Jovanovic T, Almli LM, Bradley B, Rothbaum BO, et al. Association of CRP genetic variation and CRP level with elevated PTSD symptoms and physiological responses in a civilian population with high levels of trauma. Am J Psychiatry. 2015;172(4):353\u201362. https:\/\/doi.org\/10.1176\/appi.ajp.2014.14020263.","journal-title":"Am J Psychiatry"},{"key":"7_CR185","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.bbi.2017.08.022","volume":"67","author":"MW Miller","year":"2018","unstructured":"Miller MW, Maniates H, Wolf EJ, Logue MW, Schichman SA, Stone A, et al. CRP polymorphisms and DNA methylation of the AIM2 gene influence associations between trauma exposure, PTSD, and C-reactive protein. Brain Behav Immun. 2018;67:194\u2013202.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"7_CR186","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155(2):264\u201371.","journal-title":"Am J Psychiatry"},{"key":"7_CR187","doi-asserted-by":"publisher","first-page":"S1516","DOI":"10.1590\/1516-4446-2021-1740","volume":"44","author":"M Dan\u0131\u015fman Sonkurt","year":"2021","unstructured":"Dan\u0131\u015fman Sonkurt M, Alt\u0131n\u00f6z AE, K\u00f6\u015fger F, Yi\u011fitaslan S, G\u00fcle\u00e7 G, E\u015fsizo\u011flu A. Are there differences in oxidative stress and inflammatory processes between the autogenous and reactive subtypes of obsessive-compulsive disorder? A controlled cross-sectional study. Braz J Psychiatry. 2021;44:S1516. https:\/\/doi.org\/10.1590\/1516-4446-2021-1740.","journal-title":"Braz J Psychiatry"},{"issue":"7","key":"7_CR188","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1038\/mp.2017.215","volume":"23","author":"D Mataix-Cols","year":"2018","unstructured":"Mataix-Cols D, Frans E, P\u00e9rez-Vigil A, Kuja-Halkola R, Gromark C, Isomura K, et al. A total-population multigenerational family clustering study of autoimmune diseases in obsessive-compulsive disorder and Tourette\u2019s\/chronic tic disorders. Mol Psychiatry. 2018;23(7):1652\u20138.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"7_CR189","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s11920-019-1062-8","volume":"21","author":"M Gerentes","year":"2019","unstructured":"Gerentes M, Pelissolo A, Rajagopal K, Tamouza R, Hamdani N. Obsessive-compulsive disorder: autoimmunity and Neuroinflammation. Curr Psychiatry Rep. 2019;21(8):78. https:\/\/doi.org\/10.1007\/s11920-019-1062-8.","journal-title":"Curr Psychiatry Rep"},{"issue":"7","key":"7_CR190","doi-asserted-by":"publisher","first-page":"4751","DOI":"10.1007\/s12035-018-1409-x","volume":"56","author":"TD Cosco","year":"2019","unstructured":"Cosco TD, Pillinger T, Emam H, Solmi M, Budhdeo S, Matthew Prina A, et al. Immune aberrations in obsessive-compulsive disorder: a systematic review and meta-analysis. Mol Neurobiol. 2019;56(7):4751\u20139. https:\/\/doi.org\/10.1007\/s12035-018-1409-x.","journal-title":"Mol Neurobiol"},{"issue":"5","key":"7_CR191","doi-asserted-by":"publisher","first-page":"438","DOI":"10.5455\/apd.256532","volume":"18","author":"A Ekinci","year":"2017","unstructured":"Ekinci A, Ekinci O. The relationships between low grade inflammation, demographic and clinical characteristics in patients with obsessive compulsive disorder. Anadolu Psikiyatr Derg. 2017;18(5):438. https:\/\/doi.org\/10.5455\/apd.256532.","journal-title":"Anadolu Psikiyatr Derg"},{"issue":"8","key":"7_CR192","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/ajmg.b.30871","volume":"147B","author":"RJL Anney","year":"2008","unstructured":"Anney RJL, Lasky-Su J, \u00d3\u2019D\u00fashl\u00e1ine C, Kenny E, Neale BM, Mulligan A, et al. Conduct disorder and ADHD: evaluation of conduct problems as a categorical and quantitative trait in the international multicentre ADHD genetics study. Am J Med Genet B Neuropsychiatr Genet. 2008;147B(8):1369\u201378. https:\/\/doi.org\/10.1002\/ajmg.b.30871.","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"7_CR193","doi-asserted-by":"publisher","first-page":"313","DOI":"10.32598\/bcn.11.2.1489.1","volume":"11","author":"I Namjoo","year":"2020","unstructured":"Namjoo I, Alavi Naeini A, Najafi M, Aghaye Ghazvini MR, Hasanzadeh A. The relationship between antioxidants and inflammation in children with attention deficit hyperactivity disorder. Basic Clin Neurosci J. 2020;11:313\u201322. https:\/\/doi.org\/10.32598\/bcn.11.2.1489.1.","journal-title":"Basic Clin Neurosci J"},{"issue":"9","key":"7_CR194","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1111\/j.1651-2227.2007.00430.x","volume":"96","author":"TD Banerjee","year":"2007","unstructured":"Banerjee TD, Middleton F, Faraone SV. Environmental risk factors for attention-deficit hyperactivity disorder. Acta Paediatr. 2007;96(9):1269\u201374.","journal-title":"Acta Paediatr"},{"issue":"11","key":"7_CR195","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1177\/1087054713510354","volume":"19","author":"N Joseph","year":"2015","unstructured":"Joseph N, Zhang-James Y, Perl A, Faraone SV. Oxidative stress and ADHD: a meta-analysis. J Atten Disord. 2015;19(11):915\u201324. https:\/\/doi.org\/10.1177\/1087054713510354.","journal-title":"J Atten Disord"},{"issue":"5","key":"7_CR196","doi-asserted-by":"publisher","first-page":"398","DOI":"10.23736\/S2724-5276.16.04642-9","volume":"73","author":"R Donfrancesco","year":"2021","unstructured":"Donfrancesco R, Nativio P, Borrelli E, Giua E, Andriola E, Villa MP, et al. Serum cytokines in pediatric neuropsychiatric syndromes: focus on attention deficit hyperactivity disorder. Minerva Pediatr. 2021;73(5):398\u2013404.","journal-title":"Minerva Pediatr"},{"key":"7_CR197","doi-asserted-by":"publisher","first-page":"228","DOI":"10.3389\/fpsyt.2017.00228","volume":"8","author":"D Anand","year":"2017","unstructured":"Anand D, Colpo GD, Zeni G, Zeni CP, Teixeira AL. Attention-deficit\/hyperactivity disorder and inflammation: what does current knowledge tell us? A systematic review. Front Psychiatry. 2017;8:228. https:\/\/doi.org\/10.3389\/fpsyt.2017.00228.","journal-title":"Front Psychiatry"},{"key":"7_CR198","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.psychres.2019.05.030","volume":"278","author":"S Cortese","year":"2019","unstructured":"Cortese S, Angriman M, Comencini E, Vincenzi B, Maffeis C. Association between inflammatory cytokines and ADHD symptoms in children and adolescents with obesity: a pilot study. Psychiatry Res. 2019;278:7\u201311. https:\/\/doi.org\/10.1016\/j.psychres.2019.05.030.","journal-title":"Psychiatry Res"},{"issue":"2","key":"7_CR199","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1177\/0883073818809831","volume":"34","author":"AH Darwish","year":"2019","unstructured":"Darwish AH, Elgohary TM, Nosair NA. Serum Interleukin-6 level in children with attention-deficit hyperactivity disorder (ADHD). J Child Neurol. 2019;34(2):61\u20137. https:\/\/doi.org\/10.1177\/0883073818809831.","journal-title":"J Child Neurol"},{"key":"7_CR200","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.pbb.2019.05.005","volume":"182","author":"GA Dunn","year":"2019","unstructured":"Dunn GA, Nigg JT, Sullivan EL. Neuroinflammation as a risk factor for attention deficit hyperactivity disorder. Pharmacol Biochem Behav. 2019;182:22\u201334. https:\/\/doi.org\/10.1016\/j.pbb.2019.05.005.","journal-title":"Pharmacol Biochem Behav"},{"key":"7_CR201","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.euroneuro.2020.10.005","volume":"41","author":"LL Yang","year":"2020","unstructured":"Yang LL, Stiernborg M, Skott E, S\u00f6derstr\u00f6m \u00c5, Giacobini M, Lavebratt C. Proinflammatory mediators and their associations with medication and comorbid traits in children and adults with ADHD. Eur Neuropsychopharmacol. 2020;41:118\u201331. https:\/\/doi.org\/10.1016\/j.euroneuro.2020.10.005.","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"7_CR202","first-page":"329","volume":"18","author":"M Hariri","year":"2012","unstructured":"Hariri M, Djazayery A, Djalali M, Saedisomeolia A, Rahimi A, Abdolahian E. Effect of n-3 supplementation on hyperactivity, oxidative stress and inflammatory mediators in children with attention-deficit-hyperactivity disorder. Malays J Nutr. 2012;18(3):329\u201335.","journal-title":"Malays J Nutr"},{"issue":"3","key":"7_CR203","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1586\/14737175.2016.1146591","volume":"16","author":"KM Antshel","year":"2016","unstructured":"Antshel KM, Zhang-James Y, Wagner KE, Ledesma A, Faraone SV. An update on the comorbidity of ADHD and ASD: a focus on clinical management. Expert Rev Neurother. 2016;16(3):279\u201393. https:\/\/doi.org\/10.1586\/14737175.2016.1146591.","journal-title":"Expert Rev Neurother"},{"key":"7_CR204","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.bbi.2020.04.008","volume":"88","author":"F Yin","year":"2020","unstructured":"Yin F, Wang H, Liu Z, Gao J. Association between peripheral blood levels of C-reactive protein and autism Spectrum disorder in children: a systematic review and meta-analysis. Brain Behav Immun. 2020;88:432\u201341. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.008.","journal-title":"Brain Behav Immun"},{"issue":"2","key":"7_CR205","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s12012-012-9154-2","volume":"12","author":"AS Reece","year":"2012","unstructured":"Reece AS. High-sensitivity CRP in opiate addiction: relative and age-dependent elevations. Cardiovasc Toxicol. 2012;12(2):149\u201357. https:\/\/doi.org\/10.1007\/s12012-012-9154-2.","journal-title":"Cardiovasc Toxicol"},{"key":"7_CR206","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2019.06.018","volume":"204","author":"RB Lu","year":"2019","unstructured":"Lu RB, Wang TY, Lee SY, Chen SL, Chang YH, See Chen P, et al. Correlation between interleukin-6 levels and methadone maintenance therapy outcomes. Drug Alcohol Depend. 2019;204:107516. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.06.018.","journal-title":"Drug Alcohol Depend"},{"key":"7_CR207","doi-asserted-by":"publisher","first-page":"155472","DOI":"10.1016\/j.cyto.2021.155472","volume":"141","author":"CB Ribeiro","year":"2021","unstructured":"Ribeiro CB, de Oliveira Feitosa de Castro F, Dorneles GP, de Sousa Barros JB, Silva JM, Tavares C, et al. The concomitant use of cannabis and cocaine coexists with increased LPS levels and systemic inflammation in male drug users. Cytokine. 2021;141:155472. https:\/\/doi.org\/10.1016\/j.cyto.2021.155472.","journal-title":"Cytokine"},{"issue":"4","key":"7_CR208","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1093\/alcalc\/agh059","volume":"39","author":"H Alho","year":"2004","unstructured":"Alho H. Alcohol misuse increases serum antibodies to oxidized ldl and c-reactive protein. Alcohol Alcohol. 2004;39(4):312\u20135. https:\/\/doi.org\/10.1093\/alcalc\/agh059.","journal-title":"Alcohol Alcohol"},{"issue":"1","key":"7_CR209","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1111\/acer.14228","volume":"44","author":"X Garc\u00eda-Calvo","year":"2020","unstructured":"Garc\u00eda-Calvo X, Bolao F, Sanvisens A, Zuluaga P, Tor J, Muga R, et al. Significance of markers of monocyte activation (CD163 and sCD14) and inflammation (IL-6) in patients admitted for alcohol use disorder treatment. Alcohol Clin Exp Res. 2020;44(1):152\u20138. https:\/\/doi.org\/10.1111\/acer.14228.","journal-title":"Alcohol Clin Exp Res"},{"key":"7_CR210","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fendo.2020.00159","volume":"11","author":"YY Xu","year":"2020","unstructured":"Xu YY, Ge JF, Chen J, Liang J, Pang LJ, Gao WF, et al. Evidence of a relationship between plasma Leptin, not Nesfatin-1, and craving in male alcohol-dependent patients after abstinence. Front Endocrinol. 2020;11:159. https:\/\/doi.org\/10.3389\/fendo.2020.00159.","journal-title":"Front Endocrinol"},{"issue":"7","key":"7_CR211","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/jcm9072081","volume":"9","author":"AJAE van de Loo","year":"2020","unstructured":"van de Loo AJAE, Mackus M, Kwon O, Krishnakumar IM, Garssen J, Kraneveld AD, et al. The inflammatory response to alcohol consumption and its role in the pathology of alcohol hangover. J Clin Med. 2020;9(7):2081. https:\/\/doi.org\/10.3390\/jcm9072081.","journal-title":"J Clin Med"},{"issue":"3","key":"7_CR212","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.alcohol.2003.09.003","volume":"31","author":"DJ Kim","year":"2003","unstructured":"Kim DJ, Kim W, Yoon SJ, Choi BM, Kim JS, Go HJ, et al. Effects of alcohol hangover on cytokine production in healthy subjects. Alcohol. 2003;31(3):167\u201370. https:\/\/doi.org\/10.1016\/j.alcohol.2003.09.003.","journal-title":"Alcohol"},{"issue":"12","key":"7_CR213","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1001\/archinte.164.12.1334","volume":"164","author":"J Wiese","year":"2004","unstructured":"Wiese J, McPherson S, Odden MC, Shlipak MG. Effect of Opuntia ficus indica on symptoms of the alcohol hangover. Arch Intern Med. 2004;164(12):1334. https:\/\/doi.org\/10.1001\/archinte.164.12.1334.","journal-title":"Arch Intern Med"},{"issue":"11","key":"7_CR214","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1089\/jmf.2017.4177","volume":"21","author":"RR Mammen","year":"2018","unstructured":"Mammen RR, Natinga Mulakal J, Mohanan R, Maliakel B, Illathu MK. Clove bud polyphenols alleviate alterations in inflammation and oxidative stress markers associated with binge drinking: a randomized double-blinded placebo-controlled crossover study. J Med Food. 2018;21(11):1188\u201396. https:\/\/doi.org\/10.1089\/jmf.2017.4177.","journal-title":"J Med Food"},{"issue":"1","key":"7_CR215","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2011-000494","volume":"2","author":"TB Rajavashisth","year":"2012","unstructured":"Rajavashisth TB, Shaheen M, Norris KC, Pan D, Sinha SK, Ortega J, et al. Decreased prevalence of diabetes in marijuana users: cross-sectional data from the National Health and nutrition examination survey (NHANES) III. BMJ Open. 2012;2(1):e000494. https:\/\/doi.org\/10.1136\/bmjopen-2011-000494.","journal-title":"BMJ Open"},{"issue":"2","key":"7_CR216","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.drugalcdep.2013.08.027","volume":"133","author":"EJ Costello","year":"2013","unstructured":"Costello EJ, Copeland WE, Shanahan L, Worthman CM, Angold A. C-reactive protein and substance use disorders in adolescence and early adulthood: a prospective analysis. Drug Alcohol Depend. 2013;133(2):712\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2013.08.027.","journal-title":"Drug Alcohol Depend"},{"key":"7_CR217","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.drugalcdep.2014.11.017","volume":"147","author":"O Alshaarawy","year":"2015","unstructured":"Alshaarawy O, Anthony JC. Cannabis smoking and serum C-reactive protein: a quantile regressions approach based on NHANES 2005\u20132010. Drug Alcohol Depend. 2015;147:203\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2014.11.017.","journal-title":"Drug Alcohol Depend"},{"key":"7_CR218","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.drugalcdep.2019.01.021","volume":"198","author":"EG Ferguson","year":"2019","unstructured":"Ferguson EG, Mannes ZL, Ennis N. Is marijuana use associated with lower inflammation? Results from waves III and IV of the national longitudinal study of adolescent to adult health. Drug Alcohol Depend. 2019;198:162\u20137. https:\/\/doi.org\/10.1016\/j.drugalcdep.2019.01.021.","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"7_CR219","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1139\/apnm-2019-0300","volume":"45","author":"JK Lisano","year":"2020","unstructured":"Lisano JK, Kisiolek JN, Smoak P, Phillips KT, Stewart LK. Chronic cannabis use and circulating biomarkers of neural health, stress, and inflammation in physically active individuals. Appl Physiol Nutr Metab. 2020;45(3):258\u201363. https:\/\/doi.org\/10.1139\/apnm-2019-0300.","journal-title":"Appl Physiol Nutr Metab"},{"issue":"1\u20132","key":"7_CR220","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.imlet.2013.07.001","volume":"153","author":"A Ghazavi","year":"2013","unstructured":"Ghazavi A, Mosayebi G, Solhi H, Rafiei M, Moazzeni SM. Serum markers of inflammation and oxidative stress in chronic opium (Taryak) smokers. Immunol Lett. 2013;153(1\u20132):22\u20136. https:\/\/doi.org\/10.1016\/j.imlet.2013.07.001.","journal-title":"Immunol Lett"},{"issue":"3","key":"7_CR221","first-page":"292","volume":"20","author":"F Mirzaeipour","year":"2013","unstructured":"Mirzaeipour F, Azdaki N, Mohammadi GA, Addasi E. The effects of opium addiction through different administration routes on inflammatory and coagulation factors. J Kerman Univ Med Sci. 2013;20(3):292\u2013300.","journal-title":"J Kerman Univ Med Sci"},{"issue":"1","key":"7_CR222","first-page":"17","volume":"9","author":"N Azdaki","year":"2017","unstructured":"Azdaki N, Zardast M, Anani-Sarab G, Abdorrazaghnaejad H, Ghasemian MR, Saburi A. Comparison between Homocysteine, fibrinogen, PT, PTT, INR and CRP in male smokers with\/without addiction to opium. Addict Health. 2017;9(1):17\u201323.","journal-title":"Addict Health"},{"issue":"2","key":"7_CR223","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/s0304-3959(99)00110-4","volume":"83","author":"S Perrot","year":"1999","unstructured":"Perrot S, Guilbaud G, Kayser V. Effects of intraplantar morphine on paw edema and pain-related behaviour in a rat model of repeated acute inflammation. Pain. 1999;83(2):249\u201357. https:\/\/doi.org\/10.1016\/s0304-3959(99)00110-4.","journal-title":"Pain"},{"issue":"1","key":"7_CR224","doi-asserted-by":"publisher","first-page":"e8791","DOI":"10.1371\/journal.pone.0008791","volume":"5","author":"E Glattard","year":"2010","unstructured":"Glattard E, Welters ID, Lavaux T, Muller AH, Laux A, Zhang D, et al. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One. 2010;5(1):e8791. https:\/\/doi.org\/10.1371\/journal.pone.0008791.","journal-title":"PLoS One"},{"issue":"5","key":"7_CR225","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/j.2042-3306.2010.00077.x","volume":"42","author":"JP van Loon","year":"2010","unstructured":"van Loon JP, de Grauw JC, van Dierendonck M, L'ami JJ, Back W, van Werren PR. Intra-articular opioid analgesia is effective in reducing pain and inflammation in an equine LPS induced synovitis model: analgesic and anti-inflammatory effects of intra-articular opioids in equine synovitis. Equine Vet J. 2010;42(5):412\u20139. https:\/\/doi.org\/10.1111\/j.2042-3306.2010.00077.x.","journal-title":"Equine Vet J"},{"issue":"4","key":"7_CR226","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7597","volume":"12","author":"SA Alexander","year":"2020","unstructured":"Alexander SA, Mathew Thomas V, Savage JA. Elevated C-reactive protein and role of steroids in cocaine-associated levamisole-induced vasculitis. Cureus. 2020;12(4):e7597. https:\/\/doi.org\/10.7759\/cureus.7597.","journal-title":"Cureus"},{"key":"7_CR227","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbi.2020.05.038","volume":"88","author":"Q Guo","year":"2020","unstructured":"Guo Q, Zheng Y, Shi J, Wang J, Li G, Li C, et al. Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study. Brain Behav Immun. 2020;88:17\u201327. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.038.","journal-title":"Brain Behav Immun"},{"issue":"1","key":"7_CR228","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s12974-020-01896-0","volume":"17","author":"S Najjar","year":"2020","unstructured":"Najjar S, Najjar A, Chong DJ, Pramanik BK, Kirsch C, Kuzniecky RI, et al. Central nervous system complications associated with SARS-CoV-2 infection: integrative concepts of pathophysiology and case reports. J Neuroinflammation. 2020;17(1):231. https:\/\/doi.org\/10.1186\/s12974-020-01896-0.","journal-title":"J Neuroinflammation"},{"key":"7_CR229","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbi.2020.04.027","volume":"87","author":"EA Troyer","year":"2020","unstructured":"Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. 2020;87:34\u20139. https:\/\/doi.org\/10.1016\/j.bbi.2020.04.027.","journal-title":"Brain Behav Immun"},{"issue":"18","key":"7_CR230","doi-asserted-by":"publisher","first-page":"4142","DOI":"10.3390\/jcm10184142","volume":"10","author":"P Lorkiewicz","year":"2021","unstructured":"Lorkiewicz P, Waszkiewicz N. Biomarkers of post-COVID depression. J Clin Med. 2021;10(18):4142. https:\/\/doi.org\/10.3390\/jcm10184142.","journal-title":"J Clin Med"},{"issue":"8","key":"7_CR231","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1093\/cid\/ciaa674","volume":"71","author":"A Bhargava","year":"2020","unstructured":"Bhargava A, Fukushima EA, Levine M, Zhao W, Tanveer F, Szpunar SM, et al. Predictors for severe COVID-19 infection. Clin Infect Dis. 2020;71(8):1962\u20138. https:\/\/doi.org\/10.1093\/cid\/ciaa674.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"7_CR232","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1002\/jmv.25819","volume":"92","author":"FA Lagunas-Rangel","year":"2020","unstructured":"Lagunas-Rangel FA. Neutrophil-to-lymphocyte ratio and lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): a meta-analysis. J Med Virol. 2020;92(10):1733\u20134. https:\/\/doi.org\/10.1002\/jmv.25819.","journal-title":"J Med Virol"},{"issue":"10","key":"7_CR233","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23527","volume":"34","author":"Q Liu","year":"2020","unstructured":"Liu Q, Dai Y, Feng M, Wang X, Liang W, Yang F. Associations between serum amyloid a, interleukin-6, and COVID-19: a cross-sectional study. J Clin Lab Anal. 2020;34(10):e23527. https:\/\/doi.org\/10.1002\/jcla.23527.","journal-title":"J Clin Lab Anal"},{"key":"7_CR234","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.bbi.2020.05.062","volume":"88","author":"B Yuan","year":"2020","unstructured":"Yuan B, Li W, Liu H, Cai X, Song S, Zhao J, et al. Correlation between immune response and self-reported depression during convalescence from COVID-19. Brain Behav Immun. 2020;88:39\u201343. https:\/\/doi.org\/10.1016\/j.bbi.2020.05.062.","journal-title":"Brain Behav Immun"},{"key":"7_CR235","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbi.2021.02.021","volume":"94","author":"MG Mazza","year":"2021","unstructured":"Mazza MG, Palladini M, De Lorenzo R, Magnaghi C, Poletti S, Furlan R, et al. Persistent psychopathology and neurocognitive impairment in COVID-19 survivors: effect of inflammatory biomarkers at three-month follow-up. Brain Behav Immun. 2021;94:138\u201347. https:\/\/doi.org\/10.1016\/j.bbi.2021.02.021.","journal-title":"Brain Behav Immun"},{"key":"7_CR236","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.2147\/CIA.S315405","volume":"16","author":"M-F Forget","year":"2021","unstructured":"Forget M-F, Del Degan S, Leblanc J, Tannous R, Desjardins M, Durand M, et al. Delirium and inflammation in older adults hospitalized for COVID-19: a cohort study. Clin Interv Aging. 2021;16:1223\u201330. https:\/\/doi.org\/10.2147\/CIA.S315405.","journal-title":"Clin Interv Aging"},{"issue":"8","key":"7_CR237","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1017\/S0033291717003130","volume":"48","author":"F Zheng","year":"2018","unstructured":"Zheng F, Xie W. High-sensitivity C-reactive protein and cognitive decline: the English longitudinal study of ageing. Psychol Med. 2018;48(8):1381\u20139. https:\/\/doi.org\/10.1017\/S0033291717003130.","journal-title":"Psychol Med"},{"issue":"19","key":"7_CR238","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000015605","volume":"98","author":"R Vintimilla","year":"2019","unstructured":"Vintimilla R, Hall J, Johnson L, O\u2019Bryant S. The relationship of CRP and cognition in cognitively normal older Mexican Americans: a cross-sectional study of the HABLE cohort. Medicine (Baltimore). 2019;98(19):e15605. https:\/\/doi.org\/10.1097\/MD.0000000000015605.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"7_CR239","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1002\/hbm.24594","volume":"40","author":"A Mitko","year":"2019","unstructured":"Mitko A, Rothlein D, Poole V, Robinson M, McGlinchey R, DeGutis J, et al. Individual differences in sustained attention are associated with cortical thickness. Hum Brain Mapp. 2019;40(11):3243\u201353. https:\/\/doi.org\/10.1002\/hbm.24594.","journal-title":"Hum Brain Mapp"}],"container-title":["Advances in Experimental Medicine and Biology","Neuroinflammation, Gut-Brain Axis and Immunity in Neuropsychiatric Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-19-7376-5_7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T19:04:21Z","timestamp":1679511861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-981-19-7376-5_7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9789811973758","9789811973765"],"references-count":239,"URL":"https:\/\/doi.org\/10.1007\/978-981-19-7376-5_7","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"23 March 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}